614205,273750,612921,	3-M syndrome 3 612921 614205 2 1 273750 
210210,210200,	carboxylase 2 210210 210200 1 3-Methylcrotonyl-CoA deficiency 
617698,250950,258501,617248,614739,610198,616271,	IX 617698 Leigh-like and 258501 V with 616271 I syndrome 250950 deafness encephalopathy 617248 614739 610198 aciduria III cataracts 3-methylglutaconic involvement neurologic neutropenia type VII VIII 
257920,248340,265050,	257920 syndrome 3 248340 2 1 3MC 265050 
300018,613762,616067,617480,614279,612965,400044,233420,400045,607080,	reversal 400044 8 400045 {46XY with 9 7 3 614279 612965 modifier 6 1 46XX minifascicular sex 46XY of} partial dysgenesis dosage-sensitive 613762 gonadal 617480 neuropathy 2 616067 233420 300018 4 607080 
600501,	600501 ABCD syndrome 
615954,219080,	macronodular 615954 ACTH-independent 2 adrenal hyperplasia 219080 
103285,	ADULT 103285 syndrome 
615812,605552,	605552 against} obesity-metabolic syndrome 3 {Metabolic 615812 Abdominal protection 
200100,	200100 Abetalipoproteinemia 
200110,	Ablepharon-macrostomia 200110 syndrome 
200500,	200500 Acheiropody 
200600,100800,200610,600972,	100800 Ib 600972 200600 Achondroplasia 200610 IA Achondrogenesis type II or hypochondrogenesis 
262300,216900,610024,613856,616517,	262300 7 216900 610024 3 613856 2 616517 6 Achromatopsia 4 
142690,613736,613737,	613736 613737 inversa 3 142690 Acne 2 familial 1 
607778,	607778 dysplasia Acrocapitofemoral 
614613,101800,	without resistance 614613 Acrodysostosis 101800 2 hormone 1 with or 
154400,616462,	Acrofacial type 154400 Cincinnati Nager 1 dysostosis 616462 
101900,	verruciformis 101900 Acrokeratosis 
102370,609441,602875,	Demirhan 102370 609441 Acromicric type 602875 dysplasia Maroteaux Acromesomelic 
201450,231530,201470,	short-chain 3-hydroxyacyl-CoA of dehydrogenase 201470 Acyl-CoA medium chain 201450 231530 deficiency 
615297,614814,614219,616028,100300,616589,	615297 5 syndrome 614219 3 614814 616028 2 6 1 100300 4 Adams-Oliver 616589 
608456,175100,181030,	gland pleomorphic syndrome colorectal 608456 Adenomas polyposis coli somatic multiple 175100 Gardner tumor-polyposis Adenomatous salivary Brain 2 181030 
102900,	elevated erythrocytes 102900 of triphosphate Adenosine 
103050,	Adenylosuccinase 103050 deficiency 
613743,202010,300200,201910,201810,	reversal with hyperplasia 201810 or deficiency 613743 nonclassic Adrenal 21-hydroxylase complete congenital insufficiency dehydrogenase 46XY sex 300200 3-beta-hydroxysteroid 201910 11-beta-hydroxylase Hyperandrogenism to due partial 202010 hypoplasia type 2 
new05,202300,	cortical 202300 carcinoma tumor somatic Adrenal Adrenocortical 
110800,	without Adult i phenotype 110800 cataract 
604348,615224,	syndrome phase 615224 sleep-phase 2 familial sleep 1 604348 Advanced 
601495,613502,613500,612692,613501,616941,300755,307200,	601495 612692 and 8 deficiency 613500 dominant 613501 3 616941 autosomal 300755 6 1 613502 307200 X-linked Agammaglobulinemia isolated 2 hormone 4 
225750,610329,610181,615846,615010,612952,610333,	Aicardi-Goutieres 225750 5 7 syndrome dominant 610329 recessive 3 and 2 610181 615846 6 612952 1 615010 610333 4 
118450,610205,	syndrome 118450 Alagille 2 1 610205 
300600,	Island 300600 disease eye Aland 
203100,606574,615179,203200,203290,113750,606952,	606574 oculocutaneous IA 113750 Albinism IB brown 615179 203290 modifier 606952 {Albinism of} 203200 II 203100 III IV VI type VII 
610251,	acute Alcohol 610251 to} susceptibility {Hangover sensitivity 
103900,	Aldosteronism 103900 glucocorticoid-remediable 
203655,	Alopecia universalis 203655 
614307,	Alpha-methylacyl-CoA deficiency 614307 racemase 
300448,301040,	retardation syndrome myelodysplasia somatic Alpha-thalassemia 301040 mental 300448 or 
609889,	beta gamma and delta lymphopenia severe cytomegalovirus 609889 autoimmunity Alpha infection with expansion T-cell or 
104200,301050,203780,	Alport syndrome dominant recessive 301050 autosomal 104200 203780 
104290,614820,	of 104290 hemiplegia 2 614820 Alternating childhood 
104300,104310,615590,608907,606889,607822,	104300 and late-onset Alzheimer with unusual 9 3 plaques to} disease-2 apraxia 608907 familial 1 {Alzheimer paraparesis 104310 615590 disease 606889 disease-4 spastic 18 type susceptibility 607822 
104510,613211,614832,104500,301200,204700,130900,204650,617297,615887,616221,612529,104530,617217,204690,616270,	614832 IA IH IIIA 612529 IIA1 IB 616270 IIA4 613211 204650 615887 1E hypomaturation 617217 104510 imperfecta Amelogenesis 130900 617297 IG IIA5 IJ IF 616221 104500 204690 syndrome) IIA3 IV 204700 301200 IIA2 IIA6 type IC (enamel-renal 104530 
105120,105210,613955,105250,105200,	types renal 105210 or 105250 105200 Finnish transthyretin-related 3 cutaneous familial 1 localized primary more visceral 613955 Amyloidosis 105120 type 2 hereditary 
608627,612069,105400,615515,205100,616208,602433,611895,105500,615426,602099,606070,612577,608030,183090,614696,614808,300857,613435,613954,	608627 without 205100 602433 615426 19 612577 sclerosis with 8 Amyotrophic 300857 frontotemporal or 10 612069 12 614696 9 105500 to} 1 6 614808 613954 lateral 5 21 616208 14 611895 juvenile 602099 608030 {Amyotrophic 22 to 613435 FTD 615515 sclerosis-parkinsonism 11 15 17 complex 18 606070 13} 2 20 susceptibility dementia 4 105400 183090 
170390,	170390 Andersen syndrome 
300068,312300,	without Androgen with 312300 cancer insensitivity breast 300068 partial or 
300835,206100,205950,300751,182170,new04,266120,616860,268150,301310,	without ataxia hypochromic and pyridoxine-refractory 268150 with Anemia or deficiency microcytic Rh-null 3 4 sideroblastic hemolytic 1 iron fatal regulator neonatal abnormalities 300835 near-fatal X-linked 266120 to due platelet 301310 206100 205950 overload 300751 182170 neutropenia type 2 616860 UMPH1 
300909,106100,610618,	I types III II 106100 by to} ACE and induced inhibitors type susceptibility 300909 Angioedema hereditary 610618 {Angioedema 
611773,	muscle aneurysms with nephropathy and Angiopathy 611773 hereditary cramps 
604229,107250,617315,617319,610256,137600,602588,269400,601631,	without 617315 602588 8 with or Anterior segment subtypes 7 617319 610256 3 sclerocornea multiple 269400 1 6 anomalies 5 107250 601631 dysgenesis 137600 2 604229 cataract 4 
201750,207410,	anomalies without 207410 syndrome Antley-Bixler genital and disordered steroidogenesis with 201750 or 
615436,616166,611788,132900,617349,613780,617168,	Aortic 8 aneurysm 10 615436 9 7 to} 617349 thoracic familial 6 {Aortic 616166 611788 132900 617168 11 susceptibility 613780 4 
109730,614823,	valve 109730 disease Aortic 2 1 614823 
101200,	101200 Apert syndrome 
180920,	of and lacrimal salivary Aplasia glands 180920 
new08,new09,614028,	ApoA-I Apolipoprotein A-II and C-III apoC-III combined 614028 deficiency 
207800,207900,	207800 207900 Argininosuccinic Argininemia aciduria 
610476,604400,607450,609040,107970,610193,600996,611528,615616,	607450 and 8 with 10 610476 12 604400 9 ventricular right 600996 familial palmoplantar 1 Arrhythmogenic dysplasia mild 609040 5 hair 610193 woolly 611528 keratoderma 107970 11 2 615616 13 
208000,614473,	of 614473 infancy 208000 Arterial 2 1 calcification generalized 
617468,611890,208085,108145,613404,114300,108120,614335,615065,178110,193700,601680,617146,	congenita Arthrogryposis 611890 208085 613404 114300 5D and renal 8 with proprioception 193700 impaired multiplex dysfunction 2A 108145 3 614335 touch neurogenic 1 617146 5 cell distal lethal 108120 disease 615065 178110 anterior defect myelin 617468 horn 1B type 2 cholestasis 601680 2B 
301835,	Arts 301835 syndrome 
600807,208550,607277,611960,611064,608584,	600807 208550 nasal and 611064 nocturnal in} 607277 antileukotriene to} 608584 polyps response protection diminished 5} Asthma 611960 1} traits to against} {Asthma aspirin-induced {Asthma-related treatment susceptibility 7} 2} 
601238,615217,616267,609033,608984,159550,208920,277460,	retinitis and 616267 early-onset vitamin 208920 column with deficiency Cayman Ataxia-oculomotor dominant syndrome 3 autosomal apraxia 609033 pigmentosa 1 159550 601238 hypoalbuminemia cerebellar posterior Ataxia Ataxia-pancytopenia sensory isolated 615217 type 608984 E oculomotor 4 277460 
604391,208900,	1 Ataxia-telangiectasia 208900 disorder 604391 Ataxia-telangiectasia-like 
108721,108720,256050,	I la 108721 III 256050 Atelosteogenesis Chapelle type De II dysplasia 108720 
613980,614433,614089,611493,108900,607941,612240,611363,613120,611819,614049,614050,615377,614022,612201,612794,614475,615378,613087,607554,	without 108900 613087 612240 614049 8 fibrillation with AV or conduction 607554 10 12 613980 9 7 3 613120 615377 familial defects 6 septal 5 614433 614089 14 611493 Atrial 607941 611363 614050 612201 614022 612794 16 615378 614475 defect 11 17 611819 2 4 13 
108770,615745,	SCN5A) standstill 108770 Atrial (GJA5 2 digenic or 615745 
209500,	papular Atrichia 209500 with lesions 
606217,614474,600309,614430,	septal defect heterotaxy 5 {Atrioventricular Atrioventricular syndrome to 3 614474 606217 susceptibility 614430 with 2} 4 partial 600309 
609129,617717,601071,	617717 Auditory neuropathy dominant 609129 recessive 601071 autosomal and 1 optic atrophy 
602483,614669,615706,	Auriculocondylar syndrome 602483 3 2 614669 1 615706 
613385,613551,617006,607836,615952,	6} 613385 dysmorphism Autoimmune 1} disease multisystem 2 infantile-onset {Autoimmune susceptibility 1 617006 613551 with 607836 to facial 615952 
608175,	608175 disease susceptibility 3} {Autoimmune thyroid to 
615559,601859,616100,240300,603909,	 without 615559 Autoimmune IA reversible V with or IB polyendocrinopathy I syndrome 601859 metaphyseal {Autoimmune 603909 dysplasia 616100 240300 II III type syndrome} lymphoproliferative 
614878,616050,616744,617099,617388,256040,	614878 Autoinflammatory and with deficiency antibody syndrome dyskeratosis immune 617099 familial 256040 dysregulation dermatosis lipodystrophy Autoinflammation 616744 Behcet-like enterocolitis infantile arthritis 616050 panniculitis 617388 
608805,	Avascular of femoral head 608805 necrosis the 
180500,602482,	syndrome Axenfeld-Rieger 180500 3 602482 type 1 
601088,	Ayme-Gripp 601088 syndrome 
616452,	NFKB 616452 and B-cell anergy T-cell with expansion 
218600,	Baller-Gerold 218600 syndrome 
241850,	241850 Bamforth-Lazarus syndrome 
153480,	Bannayan-Riley-Ruvalcaba 153480 syndrome 
614583,243310,	614583 syndrome 2 Baraitser-Winter 1 243310 
209885,	209885 Barber-Say syndrome 
615989,615982,615991,617406,615985,615987,615984,615990,615994,615986,615993,209900,600151,615983,605231,615981,	615985 615986 615993 209900 600151 8 10 12 615982 9 7 syndrome 3 615990 modifier 1 Bardet-Biedl 6 605231 5 14 615991 615983 of} 615994 16 615989 617406 17 615987 615984 {Bardet-Biedl 2 21 4 13 615981 
604571,209920,	lymphocyte B D 209920 TAP2 MHC deficiency I syndrome class C II 604571 group to due Bare A type complementation E 
614266,	614266 Barrett esophagus esophageal adenocarcinoma or 
149200,	Bart-Pumphrey 149200 syndrome 
602522,607364,613090,241200,300971,601678,	241200 renal with dysfunction Bartter syndrome 3 300971 Sensorineural 1 613090 digenic 601678 mild 5 607364 deafness 4a transient 602522 4b type 2 antenatal 
605462,614740,	carcinoma cell {Basal 614740 somatic 605462 7} Basal 
109400,	cell syndrome 109400 nevus Basal 
615007,213600,615483,616413,	615007 5 ganglia 213600 idiopathic 615483 6 616413 1 calcification 4 Basal 
126700,	laminar drusen 126700 Basal 
123790,	syndrome gyrata Beare-Stevenson 123790 cutis 
300376,	dystrophy Becker muscular 300376 
130650,	130650 Beckwith-Wiedemann syndrome 
210000,	210000 Behr syndrome 
614592,	614592 syndrome Bent dysplasia bone 
153670,231200,	153670 (dominant) B Giant syndrome isolated 231200 A1 Bernard-Soulier C type (recessive) disorder A2 platelet 
611809,	Bestrophinopathy recessive 611809 autosomal 
158810,616471,	myopathy 616471 Bethlem 2 1 158810 
608980,	anomalies without 608980 anorectal and renal Bifid nose with or 
617308,235555,613812,607765,214950,	defect 617308 235555 3 acid synthesis 613812 2 Bile 6 1 607765 congenital 4 214950 
135150,	syndrome 135150 Birt-Hogg-Dube 
262000,	262000 Bjornstad syndrome 
109800,	109800 {Bladder somatic Bladder cancer somatic} 
186580,	Blau 186580 syndrome 
614009,187900,616913,187800,617443,609821,615193,614201,	616913 Bleeding 8 dominant 187800 to} autosomal 617443 platelet-type 614201 disorder 16 {Bleeding 614009 187900 11 15 17 609821 20 susceptibility 615193 21 13 
617681,119580,	syndrome 617681 2 1 Blepharocheilodontic 119580 
110100,	epicanthus and inversus ptosis type 110100 2 Blepharophimosis 1 
111150,	Blood group--Lutheran 111150 inhibitor 
303700,	cone monochromacy 303700 Blue 
605039,	605039 Bohring-Opitz syndrome 
614675,615715,617052,	614675 615715 Bone syndrome 617052 3 marrow 2 1 failure 
300910,166710,612560,615221,615311,	postmenopausal Bone 166710 {Osteoporosis} early-onset 615311 {Bone 12 osteoporosis} variation to} autosomal low osteoporosis {Osteoporosis 615221 QTL18 postmenopausal} dominant} 300910 mineral QTL susceptibility} to density 612560 susceptibility 
112310,	Boomerang 112310 dysplasia 
603457,	syndrome 603457 Bosma arhinia microphthalmia 
607475,	dystrophy retinal Bothnia 607475 
215470,	215470 Boucher-Neuhauser syndrome 
113100,112500,113000,616849,615072,112600,613382,113300,113200,611377,	113100 112500 113000 D 616849 B1 A1 615072 C 112600 type 113300 113200 613382 E B2 E2 A2 Brachydactyly 611377 
612847,113500,	mild 3 612847 and metaphyseal 113500 type Brachyolmia changes epiphyseal with 4 
608415,	Bradyopsia 608415 
607595,	anomalies without ocular 607595 disease vessel small Brain with or 
608389,602588,113650,610896,	without cataracts syndrome 610896 3 113650 Branchiootic Branchiootorenal 602588 2 1 608389 with or 
614291,613399,612555,604370,new73,114480,	614291 and cancer male 604370 early-onset to} {Breast familial 3} protection 613399 colorectal somatic cancer, 612555 lobular} 1} {Breast-ovarian Breast to against} invasive 4} susceptibility ductal} 2} 114480 
613021,613071,211400,	elevated without {Bronchiectasis 613021 3 of} chloride modifier 2 sweat 1 with 211400 613071 or Bronchiectasis 
605041,	Brooke-Spiegler 605041 syndrome 
614707,211530,	Brown-Vialetto-Van 614707 syndrome Laere 2 1 211530 
609220,259450,	syndrome 259450 2 609220 Bruck 1 
601144,613119,611777,611875,613120,611876,612838,616399,613123,	Brugada 5 7 601144 syndrome 613119 9 3 611777 611875 613120 2 611876 612838 6 1 616399 8 4 613123 
609536,613652,613789,610102,613783,613825,613779,217000,612446,new18,613790,614380,614379,	613789 613783 C1q C6/C7 C9 C2 613790 614380 C1s C3 deficiency I C5 Combined C4a 613652 C4B C6 II 614379 609536 C8 610102 613825 type 613779 217000 612446 C7 
601338,	601338 CAPOS syndrome 
600142,	CARASIL 600142 syndrome 
610474,	610474 CATSHL syndrome 
214800,	CHARGE 214800 syndrome 
308050,	308050 CHILD syndrome 
607115,	CINCA 607115 syndrome 
300831,	300831 CK syndrome 
612918,	CLOVE 612918 somatic syndrome 
216360,	COACH 216360 syndrome 
617306,	COMMAD 617306 syndrome 
606963,	of chronic rate lung obstructive to} function in 606963 disease susceptibility COPD {Pulmonary decline 
608836,600649,255110,255120,	608836 neonatal 255110 stress-induced myopathic 255120 lethal IA type infantile II 600649 CPT hepatic deficiency 
114000,	114000 disease Caffey 
131300,	disease Camurati-Engelmann 131300 
212050,613108,616445,	616445 9 recessive autosomal 2 613108 familial Candidiasis 212050 4 
163000,608354,	mosaic 608354 malformation Capillary somatic malformation-arteriovenous malformations 1 163000 congenital 
237300,	I 237300 Carbamoylphosphate synthetase deficiency 
114900,	intestinal 114900 tumors Carcinoid 
115080,612838,	defect {Cardiac Cardiac 115080 to} susceptibility 612838 conduction nonspecific 
314400,212093,	defect 314400 developmental valvular 212093 X-linked dysplasia Cardiac 
604377,615119,616501,	Cardioencephalomyopathy 1 oxidase 604377 615119 4 616501 2 c infantile to cytochrome due fatal deficiency 
615280,615279,115150,615278,	syndrome 3 4 115150 615278 2 615279 615280 Cardiofaciocutaneous 
115200,613172,605362,613122,605676,600858,613642,611878,192600,606685,612124,115197,613838,612877,611879,115210,608758,613876,617047,613874,615916,613286,612098,615373,615184,601154,615235,613424,609909,613243,611407,612158,608569,608751,302045,613765,613881,26,613251,613252,615248,115196,115195,601494,613255,613697,611615,604765,607487,613873,613690,613694,601493,615396,612422,604145,613426,	613172 611878 192600 613838 8 617047 1NN 615916 613874 613286 1MM 1HH 1Y familial 6 609909 611407 612158 14 hair keratoderma 1V 613251 615248 1BB 15 115195 611615 604765 2 dilated 613690 613694 615396 612422 13 1J and 605676 hypertrophic 600858 115197 12 1C 611879 9 1II 115210 1D 1DD 608758 3 23 612098 615373 615184 1R 601154 1X 608569 woolly 1U 302045 1Z restrictive 16 26 1A 11 601494 1EE 20 1JJ without 115200 1O 1GG 605362 613642 with 7 24 1E 1KK 1S digenic 615235 Cardiomyopathy 25 608751 1LL 1G 613765 22 613881 613252 18 613255 1AA 604145 3B 613122 606685 612124 1L or 1I 612877 10 613876 1 613424 1FF 613243 5 1W 1CC 115196 17 LVNC 613697 607487 613873 601493 4 1P 613426 
157800,	157800 syndrome Cardiospondylocarpofacial 
160980,608837,	complex 160980 type variant 608837 1 Carney 
609338,	medial 609338 Carotid 1 thickness intimal 
115430,	tunnel 115430 syndrome Carpal familial 
201000,614976,	syndrome 614976 2 Carpenter 201000 
116800,611391,116200,605387,611597,616509,604307,609741,116700,601885,601547,613763,611544,613887,610202,612018,615188,610425,116100,302200,106210,212500,610019,615274,116300,116600,600881,614691,604219,612968,115700,615277,610623,	types late-onset 615277 611597 autosomal 609741 dystrophy 30 adult 116700 6 38 34 14 613887 juvenile 612018 615188 116100 302200 212500 610019 15 syndromic 604219 2 13 611391 19 40 microcornea 12 9 47 23 3 16 11 31 20 pulverulent 115700 116800 46 116200 44 605387 with 604307 multiple 22 Cataract 615274 116300 i 614691 18 116600 21 610623 juvenile-onset 10 corneal dominant 33 36 1 601885 601547 5 613763 611544 recessive 610202 610425 X-linked 106210 Aniridia 39 600881 phenotype 17 612968 616509 4 
600145,	regression Caudal 600145 syndrome 
212780,	212780 syndactyly Cenani-Lenz syndrome 
117000,	fiber Central 117000 disease core Neuromuscular type 1 with congenital uniform 
209880,	without 209880 syndrome Central Hirschsprung Haddad disease hypoventilation with congenital or 
617760,160150,615959,255200,614408,	myopathy 5 160150 Centronuclear 617760 {Centronuclear of} 3 autosomal 255200 615959 modifier 2 6 1 with fiber-type disproportion 614408 
224050,613227,614756,604290,610185,212840,604121,616875,	without ataxia and 610185 Hemosiderosis dysequilibrium with narcolepsy or atrophy psychomotor retardation syndrome dominant visual 3 604290 autosomal quadrupedal 1 locomotion 224050 613227 deafness hypogonadotropic hypogonadism 212840 616875 mental impairment to due 614756 hypoplasia aceruloplasminemia 604121 2 systemic Cerebellar nonprogressive 
105150,605714,137440,	angiopathy Iowa Arctic variants 137440 Gerstmann-Straussler 105150 amyloid disease Flemish 605714 Italian Cerebral PRNP-related Dutch 
125310,616779,	125310 subcortical dominant arteriopathy autosomal and type 2 616779 Cerebral 1 with leukoencephalopathy infarcts 
603284,116860,603285,	of and malformations-1 malformations cavernous with cerebral 603285 603284 3 cutaneous Cavernous Hyperkeratotic CNS associated retina 116860 malformations-2 capillary capillary-venous Cerebral 
612736,300352,612718,	syndrome creatine 3 612718 612736 2 Cerebral 1 300352 deficiency 
612900,617008,	612900 617008 3 palsy 2 Cerebral quadriplegic spastic 
601367,606799,	to} {Stroke 1} infarction {Ischemic susceptibility 601367 ischemic 606799 {Cerebral stroke to 
214150,610758,616570,	syndrome 214150 Cerebrooculofacioskeletal 3 616570 610758 1 4 
612199,617341,	microangiopathy and 2 612199 617341 calcifications Cerebroretinal with cysts 
204200,610003,610127,204500,610951,256731,614706,256730,615362,162350,204300,600143,601780,	204200 610127 615362 162350 8 10 7 204500 3 Northern neuronal 614706 onset variant adult 600143 1 6 5 Ceroid lipofuscinosis 601780 610003 11 610951 256731 Kufs 256730 epilepsy type 2 204300 Parry 4 13 
603956,	Cervical 603956 somatic cancer 
169100,	Char 169100 syndrome 
302800,606595,617087,607831,607791,614228,616668,192950,609260,616155,118300,616625,608323,611228,601098,616924,616687,616280,600882,605588,617017,601472,616039,601455,615185,604563,614455,615490,118200,616688,615376,214400,607734,118220,606482,601596,311070,607677,613287,608340,614895,607678,601382,609311,614436,607684,608673,607736,607706,615284,616684,	2B1 D 617087 607791 614228 talus 2I intermediate 4B3 600882 2U 2D 118200 4H 4B1 2E 607734 2S 606482 disease Vertical 311070 607677 613287 2W foot 4B2 608340 607678 609311 2N 2B 302800 B 2Z of 606595 deformity 118300 2Y 1C 608323 1D 616924 F 601455 615185 2P 616688 2K 2F 2R 1A 614895 601382 A paresis 614436 607684 1B type 20 615284 E 4C 616684 4A 607831 4F 616668 192950 Charcot-Marie-Tooth with axonal 2J 611228 601098 616687 1E 601472 616039 2T 2L 604563 614455 615490 4J 2M 214400 608673 607736 2X 4D 609260 vocal 616155 616625 dominant 616280 605588 617017 2A2B 1F 1 congenital 2CC 5 615376 recessive 118220 C 601596 X-linked 2A2A cord neuropathy 4K 607706 
610448,	610448 lupus Chilblain 
617180,	syndrome 617180 Chitayat 
614972,211600,602347,147480,615878,601847,243300,605479,617049,	of 147480 243300 pregnancy progressive intrahepatic 211600 615878 3 familial 1 617049 5 recurrent 601847 benign 614972 602347 2 605479 4 Cholestasis 
118600,	2 118600 Chondrocalcinosis 
215045,	Blomstrand type Chondrodysplasia 215045 
200700,	type 200700 Chondrodysplasia Grebe 
302960,302950,	302960 Chondrodysplasia dominant recessive 302950 X-linked punctata 
215300,612237,	215300 612237 extraskeletal Chondrosarcoma myxoid 
118700,	118700 hereditary benign Chorea 
610978,	neonatal hypothyroidism and Choreoathetosis respiratory 610978 distress 
260500,	papilloma 260500 plexus Choroid 
233690,306400,233710,233700,	of 233700 to 233710 autosomal CYBA 233690 disease 306400 NCF-2 X-linked due Chronic NCF-1 granulomatous deficiency 
608644,615482,615872,614017,613807,616037,613193,612444,615444,615505,611884,608647,613808,615481,615067,606763,300991,610852,612518,616481,612649,617091,612650,615294,614935,614874,617092,616726,615451,615500,614679,615504,244400,	dyskinesia without 608644 19 615482 615872 614017 613807 615504 616037 with 613193 or 10 612444 12 9 615444 35 7 23 615505 611884 3 608647 24 30 33 situs 1 613808 36 6 615481 615067 27 14 606763 primary 25 34 300991 5 610852 612518 616481 inversus 612649 617091 X-linked 22 612650 16 615294 26 614935 28 29 614874 Ciliary 617092 616726 11 15 17 615451 18 615500 32 614679 2 20 21 244400 13 
215600,	{Cirrhosis noncryptogenic 215600 to} susceptibility cryptogenic Cirrhosis 
215700,605814,603471,	215700 Citrullinemia adult-onset 603471 605814 type neonatal-onset II 
600987,225060,303400,616728,	and cardiac 600987 palate-ectodermal 303400 with or psychomotor retardation palate syndrome Cleft defects 616728 dysplasia lip distinctive ankyloglossia mental 225060 features facial 
119600,	anomalies only forme with Cleidocranial brachydactyly dental fruste dysplasia 119600 
609535,	Clopidogrel poor 609535 Proguanil metabolizer to responsiveness impaired 
216400,133540,	B A syndrome 216400 Cockayne type 133540 
614654,614651,607426,616276,614650,614652,612016,	614654 Q10 612016 5 7 614651 Coenzyme primary 3 607426 616276 2 6 614650 1 614652 4 deficiency 
303600,	303600 Coffin-Lowry syndrome 
616938,135900,614608,614607,614609,	5 616938 syndrome Coffin-Siris 135900 3 2 614608 1 614607 614609 4 
610313,272430,617055,	617055 syndrome sweating Cold-induced 3 272430 2 1 610313 
615522,	disease 615522 Cole 
616294,112240,	616294 syndrome Cole-Carpenter 112240 2 1 
303900,190900,303800,	protan Colorblindness 190900 303800 tritan deutan 303900 
614337,614350,114500,new78,613244,612229,612591,new73,132600,609310,614385,615083,120435,614331,608812,new17,	614337 614350 for} {Colorectal adenomatous cancer nonpolyposis 609310 614385 {Colon 10} and 608812 8 with reduced Adenocarcinoma risk 114500 7 pilomatricomas chromosomal chemotherapy to} after autosomal {Breast 132600 survival Colonic 120435 1 6 3} Pilomatricoma 5 poor cancer} colorectal of} recessive adenoma 612229 somatic 12} cancer, 1} to {Colonic advanced 613244 recurrence polyposis Colon type 2 615083 susceptibility Colorectal instability 612591 hereditary 614331 4 
611721,	SAP Combined 611721 deficiency 
233650,	granulomas humoral Combined 233650 cellular and immune defects with 
144250,602491,	Combined 144250 to} 602491 hyperlipidemia susceptibility familial combined {Hyperlipidemia 
617780,312863,	without 312863 617780 Combined immunodeficiency moderate megaloblastic and X-linked anemia with hyperhomocysteinemia or 
611719,617228,615440,616239,609060,614946,616672,616198,614096,610505,614932,616794,617713,615917,614924,610678,610498,614947,615578,613559,614582,614702,617664,614922,616974,300816,616539,	611719 617228 oxidative 615440 616239 609060 614946 616672 8 616198 10 deficiency 12 phosphorylation 9 7 23 Combined 3 24 614096 30 33 1 610505 6 614932 616794 27 615917 14 617713 5 610678 610498 616539 614947 28 26 615578 11 15 613559 17 32 614702 18 31 614582 617664 614922 2 616974 20 300816 4 614924 13 
120790,	of Complement 120790 component 4 partial deficiency 
609814,613912,610984,	factor 613912 I H D 609814 Complement 610984 deficiency 
615973,610283,616502,615860,604393,612775,610381,603649,612657,614500,602093,120970,608194,613093,600977,300476,610427,601777,304020,617236,615374,604116,613660,	615973 610283 nonprogressive 19 616502 615860 and 604393 612775 610381 dystrophy-3 603649 10 12 9 7 Cone 612657 dystrophy-2 614500 3 synaptic dystrophy 602093 6 1 loss congenital 120970 608194 5 retinal 14 613093 600977 Cone-rod 300476 610427 X-linked 601777 304020 16 disorder 617236 615374 11 15 18 604116 20 613660 21 hearing 4 13 
610805,143400,617641,	without of abnormal and 143400 with or syndrome to} tract {Congenital loss anomalies 617641 Congenital delay urinary 2 ears developmental susceptibility 610805 hearing kidney 
277180,	of absence vas deferens bilateral 277180 Congenital 
604168,614482,	614482 cataracts neuropathy dysmorphism and neurodegeneration loss Congenital 604168 hearing facial 
616266,	face 616266 of and contractures developmental hypotonia Congenital delay limbs the 
611209,607143,614576,300934,603147,608093,608779,613661,612015,615042,614727,612379,603585,610768,609180,601110,612937,607091,616829,608799,602579,212066,613612,615273,300896,613489,212065,614921,608776,616828,608540,266265,616721,606056,611182,608104,	IIn Ic 611209 IIg of glycosylation 614576 607143 603147 IIo Im 300934 IIi IIf 608093 608779 In 613661 612015 Ig Io 615042 IIm IIk 614727 Ie Ib 612379 603585 IId 609180 IIj 601110 610768 Id IIb IIe 607091 616829 608799 612937 602579 Iy 212066 613612 Il 615273 300896 613489 212065 614921 deglycosylation Iq If 608776 It IIa disorder Ik 616828 Ip Congenital 608540 266265 616721 Ia 606056 IIc Ij Ih 611182 IIl type IIp Iu 608104 IIh 
306955,615779,617364,617602,617360,614980,	types intellectual 617602 and malformations ectodermal skeletal syndrome 617364 617360 multiple defects 1 dysplasia dysmorphic nonsyndromic 615779 disorder X-linked Congenital 614980 features 306955 2 developmental heart 4 facial 
218040,	myopathy excess of muscle 218040 syndrome Costello spindles Congenital with 
615237,300048,	615237 syndrome short neuronal 300048 bowel Congenital Intestinal pseudoobstruction 
217095,	face ventricle syndrome Conotruncal arteriosus variable anomaly right malformations heart truncus Double-outlet Persistent 217095 
121050,	arachnodactyly 121050 congenital Contractural 
602066,	paroxysmal 602066 choreoathetosis familial infantile with Convulsions 
136800,607541,217400,122000,217700,122200,609140,204870,608471,613270,new19,615523,121800,609141,613267,608470,602082,613268,121850,121820,610048,121900,	136800 gelatinous 607541 and 217400 Groenouw IIIA 8 fleck endothelial I 122000 epithelial 217700 membrane 122200 Fuchs 3 polymorphous lattice 609140 autosomal dystrophy basement 204870 Reis-Bucklers 608471 613270 6 1 congenital 615523 121800 Avellino 613267 608470 602082 613268 609141 Thiel-Behnke deafness recessive 121850 drop-like posterior Corneal Schnyder 121820 perceptive 610048 clouding 121900 type 2 4 stromal 
300590,300882,122470,610759,614701,	Cornelia 300590 5 syndrome 614701 3 300882 122470 2 610759 1 de Lange 4 
300472,304100,	partial 304100 coloboma Corpus of retardation ocular micrognathia agenesis and mental 300472 with callosum 
615411,610042,614039,614115,615282,615412,615763,610031,613180,615771,	615411 Cortical malformations 8 with 615771 7 614039 syndrome 3 other brain 615763 1 6 dysplasia 613180 5 614115 occipital 615282 615412 610042 dysplasia-focal complex epilepsy 2 610031 4 
604931,614662,	614662 604931 reductase Cortisone 2 1 deficiency 
310490,	310490 Cowchock syndrome 
615109,615106,616858,612359,158350,615107,615108,	5 158350 Cowden 615109 syndrome 615106 7 3 616858 612359 2 6 1 Lhermitte-Duclos 615107 4 615108 
218330,613610,122860,614099,	1 613610 122860 Craniodiaphyseal dominant 218330 3 autosomal 614099 2 Cranioectodermal dysplasia 
122880,	122880 Craniofacial-deafness-hand syndrome 
218400,123000,	123000 recessive autosomal 218400 Craniometaphyseal dysplasia 
604757,616602,614188,new20,123100,617439,614416,615314,600775,615529,	and 600775 with {Craniosynostosis 616602 7 skeletal 3 to} other dental 6 1 craniofacial anomalies 604757 5 fusions 614188 123100 617439 radiohumeral 615529 614416 2 615314 susceptibility Craniosynostosis 4 nonspecific 
123320,	elevated serum 123320 Creatine phosphokinase 
123400,	resistance to} disease variant Creutzfeldt-Jakob {Creutzfeldt-Jakob 123400 
218800,606785,	I Crigler-Najjar syndrome 218800 type 606785 II 
612247,123500,	acanthosis nigricans syndrome 123500 612247 Crouzon with 
185020,	Cryohydrocytosis 185020 
615849,	Culler-Jones 615849 syndrome 
601707,	mosaic 601707 syndrome somatic Curry-Jones 
614434,219200,614437,614438,219100,613177,219150,612940,617402,616603,617403,123700,	614434 IIA IA 616603 IIIA 617403 IB 614437 dominant 3 autosomal 613177 IIIB laxa 219200 IID Cutis recessive 614438 612940 IIB 123700 IIC 219150 type 2 IC 617402 219100 
613977,	613977 neonatal transient Cyanosis 
132700,	Cylindromatosis familial 132700 
219500,	219500 Cystathioninuria 
219700,	cystic fibrosis aeruginosa chronic lung of} by 219700 in fibrosis} modifier disease Cystic susceptibility {Cystic infection {Pseudomonas to 
220100,219800,219900,219750,	220100 nephropathic 219900 ocular juvenile Cystinuria atypical nonnephropathic late-onset adolescent Cystinosis 219800 or 219750 
609162,	609162 dysplasia Czech 
600721,613657,	aciduria D-2-hydroxyglutaric 600721 2 613657 
261515,	protein D-bifunctional 261515 deficiency 
220500,	220500 DOOR syndrome 
124200,	disease 124200 Darier 
278800,	Sanctis-Cacchione 278800 De syndrome 
609006,616958,601072,580000,221200,613391,614945,601544,601317,614035,300614,612643,614934,603622,609706,606705,601386,601543,600994,608641,615540,601868,614152,606346,607039,604717,304500,614617,614944,611451,616044,609646,613718,617639,610220,616357,613916,605594,601071,600652,613074,616697,600965,608265,607084,612644,300066,new23,608224,613307,600974,610706,610419,600101,601369,124480,611022,601869,613285,607821,610265,124900,605583,609823,609439,614861,613079,612645,617772,609533,600316,607101,300475,614899,603720,220290,608565,616340,615629,600791,600971,617637,601316,602459,600060,617663,602092,605192,603629,614614,304400,610153,	609006 616958 601072 {Deafness 580000 221200 84A inner 613391 614945 enlarged 601544 8 601317 ear 614035 300614 612643 autosomal 614934 mitochondrial dentinogenesis 603622 18B 30 609706 606705 Deafness 6 59 38 34 601386 53 14 cardiomyopathy 64 601543 600994 608641 615540 601868 614152 15 42 2 606346 607039 18A 13 2B 604717 86 and 614617 304500 hypertrophic 40 614944 84B 611451 cerebral 12 9 616044 35 23 GJB6 609646 3 613718 4 617639 77 peripheral 610220 616357 610153 613916 605594 4B 37 601071 neurosensory 600652 613074 616697 28 600965 26 16 107 1A 607084 300066 612644 608265 608224 dystonia 11 unilateral 613307 agenesis 31 600974 1B 610706 20 98 600101 4A 601369 610419 124480 without 611022 601869 613285 607821 vestibular myopia with asymmetric 2A 68 GJB3 610265 7 124900 605583 24 609823 609439 microtia 614861 74 digenic 105 inflammation 613079 25 of} 73 612645 3A 49 76 22 29 617772 609533 aqueduct 63 600316 involvement 607101 GJB2 300475 21 614899 603720 220290 3B 608565 65 616340 or 10 615629 dominant 600791 50 48 600971 onychodystrophy hypomyelination 67 modifier 36 1 617637 congenital 5 89 601316 70 recessive 602459 microdontia 41 56 X-linked 600060 69 602092 39 106 17 neuropathy 605192 93 79 603629 614614 304400 617663 
194380,616689,	without Dehydrated perinatal pseudohyperkalemia with edema and 2 194380 616689 hereditary or stomatocytosis 
145900,	disease Dejerine-Sottas 145900 
117300,600274,600795,176500,new97,127750,	without 600274 Danish vascular, 127750 body with or frontotemporal to} 176500 600795 British familial Dementia parkinsonism {Lewy {Dementia, Lewy 117300 susceptibility dementia nonspecific 
300555,300009,	Dent disease 2 300555 300009 
125420,125400,	I Dentin microdontia 125420 and teeth misshapen type 125400 II with dysplasia 
125500,125490,	Shields III type II Dentinogenesis 125490 125500 imperfecta 
194080,	194080 Denys-Drash syndrome 
607907,	607907 protuberans Dermatofibrosarcoma 
125595,	Dermatopathia reticularis pigmentosa 125595 
251450,615777,	Desbuquois 615777 2 251450 1 dysplasia 
135290,	disease Desmoid 135290 hereditary 
188400,	syndrome 188400 DiGeorge 
304800,125800,125700,	Diabetes nephrogenic 125800 insipidus 304800 neurohypophyseal 125700 
606176,616087,606394,601942,601283,125852,609812,610508,610199,612227,616329,613370,610582,612520,222100,125853,610374,600320,601410,610549,616511,612225,601388,613375,612522,	Diabetes without acanthosis 606176 nigricans noninsulin-dependent} of IX Maturity-onset 10} 616087 601942 606394 mellitus with or 10 I 601283 young 125852 609812 3 to} insulin-dependent 610508 610199 noninsulin-dependent onset {Diabetes 612227 14} 1 6 congenital the 613370 610582 616329 neonatal 22} 5} association 612520 222100 insulin-dependent} 12} 1} 125853 non-insulin-dependent 610374 ketosis-prone with} diabetes II 13 601410 600320 to 610549 transient 11 hypothyroidism permanent 612225 601388 613375 insulin-resistant neurologic 616511 type 2 20 susceptibility {Maturity-onset VII late 2} features 612522 VIII 
612563,105650,612527,615909,610629,606164,612561,612562,612528,613308,613309,	612563 Diamond-blackfan 612561 anemia 8 with 10 9 7 612527 3 1 612528 6 105650 5 615909 610629 606164 mandibulofacial 612562 dysostosis 613308 613309 15 Diamond-Blackfan 4 13 
610187,	610187 3 hernia Diaphragmatic 
613217,214700,610370,614616,616868,270420,	214700 614616 malabsorptive 8 with 3 6 1 congenital 5 613217 tufting enteropathy Diarrhea sodium syndromic 610370 chloride 616868 270420 secretory 4 
222600,	Diastrophic 222600 broad variant bone-platyspondylic dysplasia 
606835,	606835 Digital familial arthropathy-brachydactyly 
119900,	119900 isolated clubbing Digital congenital 
615821,	Dilated cardiomyopathy agenesis hair and woolly keratoderma tooth with 615821 
613571,	oxidoreductase steroidogenesis P450 613571 to Disordered cytochrome due 
615327,179850,615696,	615696 disease 2 615327 1 4 179850 Dowling-Degos 
228900,	228900 syndrome Pan Du 
617041,604356,	retraction 617041 syndrome 3 604356 2 Duane 
607323,	607323 Duane-radial ray syndrome 
310200,	dystrophy muscular Duchenne 310200 
223800,	disease Dyggve-Melchior-Clausen 223800 
615402,127400,	127400 Dyschromatosis 3 615402 universalis hereditaria symmetrica 
224120,224100,615631,613673,	Dyserythropoietic Ia 224120 Ib IV 615631 224100 type anemia II congenital 613673 
202400,616004,	Dysfibrinogenemia Hypofibrinogenemia Hypodysfibrinogenemia 202400 616004 Afibrinogenemia congenital 
127550,613987,613989,613988,305000,224230,613990,615190,616353,	congenita 613987 dominant 3 613988 autosomal 305000 613989 224230 1 6 5 recessive {Dyskeratosis X-linked 616353 Dyskeratosis 127550 2 4} 613990 615190 2} 4 
616921,	orofacial 616921 limb Dyskinesia and infantile-onset 
224410,	Dyssegmental Silverman-Handmaker type 224410 dysplasia 
128101,615034,224500,159900,602629,new25,new98,612067,601042,128230,617282,128100,128235,314250,615073,616398,616411,612716,617284,	without 615034 Dystonia-12 159900 Dystonia 602629 617282 and 128100 616411 314250 with 128101 or atrophy deficiency basal hyperphenylalaninemia 9 Dystonia-Parkinsonism dominant autosomal 24 childhood-onset modifier sepiapterin cervical DOPA-responsive 6 Dystonia-1 {Dystonia-1, optic 612716 617284 27 abnormalities primary 25 recessive of} 601042 reductase X-linked 16 28 26 616398 due to Dystonia-11 dopa-responsive 224500 torsion ganglia 612067 myoclonic 128230 128235 2 615073 4 
189500,614941,129490,617392,613573,616029,224900,614940,300301,604536,300291,614931,129500,225280,305100,612132,602032,	10A dysplasia-syndactyly 614941 129490 fragility 11A and Ectodermal tooth 614931 T-cell 617392 with or Witkop macular deficiency nail 189500 9 skin syndrome dominant immunodeficiency 3 autosomal 224900 614940 300301 dystrophy immune 300291 1 anhidrotic dysplasia 612132 602032 recessive hair X-linked hypohidrotic 129500 lymphedema 305100 225280 604536 613573 11B short 616029 ectrodactyly stature Clouston type 2 4 13 10B 
225200,225100,129600,	Ectopia 129600 pupillae isolated recessive lentis et autosomal 225100 225200 familial 
604292,	604292 Ectrodactyly palate ectodermal cleft syndrome 3 and lip dysplasia or 
614557,615539,606408,225410,225320,617174,225400,615349,601776,130060,130070,130050,130080,130000,	myopathy classic VIIA and periodontal cardiac kyphoscoliosis valvular progressive with progeroid 225400 deficiency musculocontractural syndrome 225410 VIIB 615349 1 loss anomalies VIIC Ehlers-Danlos 615539 form 130060 to due 130000 IV limb short 614557 stature 606408 VI 225320 617174 type tenascin 2 601776 130070 hearing 130050 X 130080 
600002,	600002 Eiken syndrome 
new27,130600,611804,	130600 Elliptocytosis-2 Elliptocytosis-1 611804 Elliptocytosis-3 
225500,	225500 Ellis-van Creveld syndrome 
614038,	Emberger 614038 syndrome 
181350,310300,612999,612998,300696,616516,614302,	612999 310300 postural Myopathy with atrophy 181350 Emery-Dreifuss 7 dominant 3 autosomal dystrophy 6 1 616516 5 muscle AD 612998 X-linked 300696 614302 muscular AR 2 4 
613001,new40,	Encephalocraniocutaneous Lipoma 613001 somatic lipomatosis 
617669,604218,617086,614388,617668,617193,300673,615924,617207,617186,	without defective amyotrophy edema and early-onset progressive with atrophy fission or 617669 604218 617086 inclusion mitochondrial severe peroxisomal familial lactic 1 brain bodies optic 617186 thin neonatal abnormalities 614388 Encephalopathy lethal corpus lipodystrophy 615924 617207 to due callosum 617668 spasticity 617193 acidosis 2 300673 leukoencephalopathy neuroserpin 
608089,	{Endometrial carcinoma to} 608089 somatic cancer Endometrial susceptibility familial 
268100,	S-cone Enhanced 268100 syndrome 
600791,	aqueduct Enlarged 600791 vestibular digenic 
226400,	verruciformis 226400 Epidermodysplasia 
131750,612138,131960,609638,132000,617294,131900,new26,131850,226650,601001,609352,615028,226730,131800,615425,131950,226600,226700,131760,226670,604129,	simplex-MP stenosis 131750 of Epidermolysis atresia 612138 pretibial and 131960 609638 132000 Herlitz with 617294 pyloric Dowling-Meara autosomal scarring modifier variant junctional atrophic feet dystrophy simplex 131900 loss 131850 1 simplex-MCR Weber-Cockayne 226650 601001 609352 AD 615028 inversa localisata recessive of} 226730 lethal acantholytic 131800 Ogna 615425 pruriginosa hair 131950 226600 226700 bullosa generalized benign 131760 226670 AR muscular non-Herlitz {Epidermolysis 604129 Koebner type 2 Bart EBD dystrophica hands nonspecific 
113800,	hyperkeratosis Epidermolytic 113800 
617276,300088,611136,254780,254900,616341,254800,612269,613060,616436,617665,617391,617166,615473,617106,616645,616577,617020,617290,300884,300672,617389,600512,604233,614018,614417,607876,617339,617711,615476,611726,613720,308350,616339,607628,616366,607682,612899,616211,611277,615871,617113,614959,611942,617132,605375,266100,617118,617116,617162,614558,616139,600513,616346,604364,615338,614847,616981,616187,607208,612949,613863,615005,613722,616056,612164,616685,617153,616647,617105,245570,300607,607681,607631,615744,616409,612437,615369,609304,613721,615859,610353,616457,617350,617281,604403,613477,615905,300491,	51 617276 renal 300088 611136 8 52 (Lafora) 254780 retardation 254900 616341 254800 adult 30 11} familial 6 loss 612269 613060 38 34 53 14 juvenile inclusions 616436 12} encephalopathy 1} disorders 617665 617391 42 617166 615473 absence 617106 616645 2 616577 susceptibility 617020 617290 300884 300672 seizures 2B 13 (Unverricht 19 617389 600512 and 604233 early-onset progressive 614018 12 614417 nocturnal 35 behavior 607876 23 47 3 617339 9 9} 617711 43 615476 611726 613720 37 308350 616339 variable 607628 foci (Dravet idiopathic plus 16 28 26 1A 616366 {Epilepsy 607682 11 speech 612899 B6-dependent 616211 611277 31 54 615871 1B type 7} 617113 hearing without 6} 614959 611942 617132 46 605375 266100 617118 44 vitamin 617116 with 617162 2A 614558 600513 616139 7 45 to} 24 14} focal 616346 604364 615338 614847 failure 300491 27 616981 early 8} 616187 25 of} frontal 49 disorder 29 mental 612949 607208 to syndrome) lobe {Dravet 613863 615005 18 613722 616056 4} 612164 616685 617153 616647 617105 245570 pyridoxine-dependent 300607 607681 10} 607631 615744 or Epileptic syndrome 50 48 childhood-onset modifier temporal 616409 33 612437 36 1 learning 615369 609304 613721 615859 febrile childhood 5 5} 610353 Epilepsy 41 616457 X-linked infantile Lundborg) 56 617350 617281 generalized 604403 39 17 32 myoclonic 613477 615905 disabilities 2} 4 intracellular 
607078,617719,132450,226900,600204,615923,600969,132400,	without myopathy and myopia with or 7 3 multiple 600204 615923 1 600969 dysplasia 5 deafness 607078 132450 chondrodysplasia 226900 Epiphyseal type 2 617719 Miura 4 132400 
160120,108500,612656,128200,613855,	dyskinesia 1 5 ataxia syndrome 160120 Episodic 108500 myokymia type 2 612656 6 128200 613855 or kinesigenic 
615552,615551,	pain 615552 syndrome 3 Episodic 2 familial 615551 
122400,	recurrent dystrophy 122400 erosion Epithelial 
153650,	Epstein 153650 syndrome 
245340,	lactate defect 245340 transporter Erythrocyte 
222800,609820,263400,611783,new29,133100,	222800 609820 3 4 mutase Erythrocytosis somatic 263400 2 bisphosphoglycerate familial to 611783 due 133100 deficiency 
615508,	hypotrichosis and IgE 615508 Erythroderma keratoderma palmoplantar with congenital hyper 
617525,617756,617524,133200,617526,	progressiva 617525 5 Erythrokeratodermia 3 617756 617524 et variabilis 2 1 133200 4 617526 
265000,	265000 Escobar syndrome 
133239,new99,	carcinoma cell squamous to} 133239 somatic cancer, cancer alcohol-related, susceptibility {Esophageal Esophageal 
614782,616736,190300,	{Essential 5 614782 616736 190300 Essential 1} tremor hereditary 4 
615363,	Estrogen 615363 resistance 
616854,	Even-plus 616854 syndrome 
133701,133700,	133700 133701 Exostoses type multiple 2 1 
193235,601813,305390,133780,new119,613310,617572,	of 601813 133780 vitreoretinopathy with 7 neovascular 1 dysplasia inflammatory 5 phalangeal Retinopathy 613310 X-linked epiphyseal Exudative 617572 Vitreoretinopathy 193235 305390 2 prematurity 4 
300321,300422,	syndrome 300321 300422 FG 2 4 
615139,	FILS 615139 syndrome 
234000,613235,613225,227500,613625,227400,612416,227600,	factor 234000 of and V deficiency dominant autosomal 613225 227400 612416 227600 recessive XIIIB Factor XI combined XII XIIIA 613235 227500 613625 VII X VIII 
125350,	of primary Failure tooth eruption 125350 
616415,617100,	3 polyposis adenomatous 616415 4 Familial 617100 
120100,614468,611762,	cold-induced 120100 inflammatory syndrome 3 cold autoinflammatory 2 614468 1 Familial 611762 
300514,227650,614083,615272,614082,600901,227645,603467,613951,605724,609054,616435,609053,613390,227646,610832,	300514 T B 613951 L anemia 614082 610832 I D1 N Q 605724 609054 F O P 227645 603467 G C D2 group 227650 614083 615272 A 600901 Fanconi J 616435 609053 complementation E 613390 227646 
616026,227810,	young of maturity-onset syndrome renotubular Fanconi diabetes 227810 616026 with 4 the Fanconi-Bickel 
228000,	228000 Farber lipogranulomatosis 
158901,	muscular dystrophy 2 Fascioscapulohumeral 158901 digenic 
609016,	acute Fatty deficiency of 609016 pregnancy liver LCHAD 
134700,	134700 Favism 
614418,613863,611277,604403,	614418 11 604403 613863 611277 3B Febrile 3A familial 8 seizures 
153640,	Fechtner 153640 syndrome 
614326,164280,	syndrome 614326 164280 Feingold 2 1 
208150,	Fetal akinesia 208150 deformation sequence 
141749,	Fetal of Hereditary hemoglobin fetal quantitative locus persistence 1 trait 141749 
614524,228520,	614524 Fibrochondrogenesis 2 228520 1 
617626,	Fibromatosis gingival 5 617626 
616219,602078,600638,135700,	muscles 5 of extraocular 3B 3A Fibrosis 2 600638 1 616219 congenital 602078 135700 
136120,	disease Fish-eye 136120 
607341,	Focal cortical somatic 607341 type II dysplasia 
227260,614974,	Focal 3 227260 614974 Setleis type dermal dysplasia 4 facial 
616032,616220,	Focal 9 glomerulosclerosis 616032 616220 8 segmental 
609218,136520,	without segment misrouting 609218 hypoplasia and Foveal nerve dysgenesis 2 1 with anterior optic or 136520 
300624,300623,	Fragile ataxia syndrome 300623 tremor 300624 X or 
617667,219000,617666,	Fraser 617666 syndrome 3 617667 2 1 219000 
136680,	Frasier 136680 syndrome 
305620,617137,	617137 305620 2 1 dysplasia Frontometaphyseal 
136760,613451,	136760 613451 Frontonasal 2 1 dysplasia 
105550,616437,615911,616439,	lateral 616437 Frontotemporal 615911 105550 3 and 2 1 dementia sclerosis amyotrophic 4 or 616439 
607485,612069,	612069 Frontotemporal degeneration primary inclusions TARDBP-related ubiquitin-positive 607485 lobar progressive with Aphasia 
229700,229600,	intolerance Fructose-16-bisphosphatase Fructose 229600 229700 hereditary deficiency 
228930,	228930 Fuhrmann syndrome 
606812,	Fumarase 606812 deficiency 
248200,136880,	albipunctatus 248200 flavimaculatus 136880 Fundus 
606777,612126,	syndrome childhood onset severe 606777 2 infantile 1 612126 GLUT1 deficiency 
230500,272800,230650,230600,272750,	I 230500 III Tay-Sachs 272800 GM2-gangliosidosis GM1-gangliosidosis 230650 type variant disease several forms 230600 II 272750 AB 
603358,	603358 GRACILE syndrome 
611465,600803,	{Gallbladder 611465 disease 4} 1 Gallbladder 600803 
301006,251300,617730,617729,617731,	Galloway-Mowat 5 syndrome 301006 3 251300 617730 2 X-linked 617729 1 4 617731 
137215,613659,	risk without 137215 palate cleft H. pylori after somatic and diffuse cancer lip Gastric {Gastric familial infection} with or 613659 
606764,	Gastrointestinal tumor 606764 somatic familial stromal 
231000,230800,230900,608013,231005,610539,	I Gaucher 231000 III perinatal 230800 lethal atypical 230900 IIIC disease type II 608013 231005 610539 
607313,617542,	1 617542 palsy horizontal 2 familial Gaze progressive with 607313 scoliosis 
614185,231050,	614185 Geleophysic 2 1 dysplasia 231050 
606170,	606170 Genitopatellar syndrome 
206700,	206700 Gillespie syndrome 
263210,	Gillessen-Kaesbach-Nishimura 263210 syndrome 
273800,	273800 thrombasthenia Glanzmann 
613100,603383,609887,231300,137760,617272,137750,613086,	1O 613100 D open 617272 or 3 angle onset 231300 adult F 1 congenital primary juvenile 603383 G 609887 3A 137760 Glaucoma 137750 613086 1A E 
616568,613029,613028,137800,	{Glioblastoma 613028 somatic Glioblastoma 613029 1} somatic} susceptibility 137800 9} 3} {Glioma 2} to 616568 
609886,	isosthenuria hyperuricemia and Glomerulocystic 609886 disease with kidney 
614131,603965,616002,612551,603278,607832,613237,	616002 Glomerulosclerosis renal 603278 nondiabetic {End-stage 607832 613237 603965 614131 7 3 to} focal 6 1 {Glomerulosclerosis 5 disease 612551 2 susceptibility 4 segmental 
615962,202200,614736,607398,	without 615962 Glucocorticoid deficiency resistance ACTH to 202200 2 unresponsiveness due mineralocorticoid with 4 or 614736 607398 
231690,231670,231680,	I III 231670 231680 IIA IIC acidemia type 231690 IIB Glutaric aciduria 
266130,	266130 synthetase Glutathione deficiency 
617301,605899,606664,	serum N-methyltransferase Glycine normal 605899 encephalopathy 617301 glycine 606664 with deficiency 
232800,232220,232300,232400,611881,611556,232240,612933,261740,240600,261670,306000,232700,232200,232500,613027,	Ic 232800 232220 of 232300 232240 Glycogen 232200 IXc 232500 IXa1 Ib storage 611881 611556 IXa2 612933 240600 306000 232700 congenital 613027 muscle IIIa 232400 lethal disease XI 261740 II XII Ia IV VI 0 type heart VII IIIb 261670 X liver 
166260,	166260 dysplasia Gnathodiaphyseal 
138800,	without cell Sertoli-Leydig Goiter tumors multinodular 1 with 138800 or 
602361,	Gracile dysplasia 602361 bone 
215140,	skeletal dysplasia 215140 Greenberg 
175700,	175700 cephalopolysyndactyly Greig syndrome 
607624,214450,609227,	syndrome 609227 3 607624 type 2 1 Griscelli 214450 
182230,615925,173100,604271,new37,262400,612781,245590,	182230 IA with growth 245590 IB deficiency pituitary 604271 immunodeficiency insensitivity Growth dysplasia anomalies 615925 173100 Increased Septooptic II responsiveness to partial isolated type 262400 hormone 612781 
612938,608747,617093,	intellectual 608747 and hypotonia 617093 with deficiency retardation dysmorphism Growth hepatopathy deafness 612938 IGF1 disorder mental delay to due developmental facial 
176305,	176305 Guttmacher syndrome 
607236,	HARP 607236 syndrome 
new100,604091,	augmented} HDL type 2 hormone replacement, {HDL to response 604091 deficiency 
609016,	of syndrome HELLP 609016 pregnancy maternal 
246450,605911,	HMG-CoA 605911 246450 synthase-2 lyase deficiency 
300323,	HPRT-related 300323 gout 
245010,	245010 Haim-Munk syndrome 
102500,	syndrome 102500 Hajdu-Cheney 
140000,	140000 syndrome Hand-foot-uterus 
234500,	234500 disorder Hartnup 
615465,	Hartsfield 615465 syndrome 
140350,	Hawkinsinuria 140350 
106260,	Hay-Wells 106260 syndrome 
113900,	IA type 113900 progressive nonprogressive Heart block 
610140,	Slovenian syndrome Heart-hand type 610140 
616617,234580,	234580 syndrome 616617 2 Heimler 1 
140700,	Heinz anemias alpha- anemia beta- body 140700 
602089,	capillary Hemangioma to} {Hemangioma somatic susceptibility infantile 602089 
141200,	familial benign 141200 Hematuria 
614034,	oxygenase-1 deficiency 614034 Heme 
235200,613313,602390,604250,606069,	2A {HFE 235200 hemochromatosis Hemochromatosis of} 602390 613313 3 modifier type 604250 606069 4 2B 
613978,	Hemoglobin 613978 H nondeletional disease 
612631,300908,612300,230450,615512,231900,613470,235700,	without hexokinase gamma-glutamylcysteine isomerase anemia Hemolytic 231900 with immune-mediated or synthetase deficiency glucose phosphate 615512 kinase 613470 CD59-mediated 612631 300908 612300 230450 glutathione adenylate to due triosephosphate G6PD polyneuropathy nonspherocytic 235700 
603552,613101,608898,603553,	Hemophagocytic 603552 5 608898 3 613101 2 lymphohistiocytosis familial 4 603553 
306700,306900,	306700 B A 306900 Hemophilia 
235510,616006,	235510 616006 lymphangiectasia-lymphedema Hennekam syndrome 2 1 
614025,	lipase 614025 Hepatic deficiency 
235550,	immunodeficiency venoocclusive 235550 disease with Hepatic 
142330,114550,	carcinoma 114550 adenoma somatic cancer Hepatocellular type 142330 Hepatoblastoma Hepatic childhood 
604484,606071,601152,	VIA IIc sensory Hereditary neuropathy 604484 606071 and type motor Okinawa 601152 
203300,614075,614072,608233,614074,614077,614073,614076,	5 7 203300 syndrome 3 614075 608233 614072 2 614074 6 Hermansky-Pudlak 1 614077 8 614073 4 614076 
616749,617205,306955,614779,613751,605376,270100,	616749 5 617205 306955 visceral 7 recessive autosomal 614779 270100 Heterotaxy 2 X-linked 6 1 8 4 605376 613751 
300049,	300049 periventricular Heterotopia 
614226,609637,142946,610828,142945,157170,610829,	5 9 11 7 614226 3 609637 142946 142945 2 610828 Holoprosencephaly 157170 4 610829 
236270,277410,236250,236200,250940,	types and hyperhomocysteinemic anemia Thrombosis deficiency 236270 cbl 236250 variant MTHFR 1 cblG 236200 Homocystinuria to due cblD 277410 nonresponsive type B6-responsive complementation E 250940 Homocystinuria-megaloblastic 
143100,603218,	143100 Huntington disease disease-like 1 603218 
176670,	progeria Hutchinson-Gilford 176670 
231090,614293,	mole recurrent 2 1 Hydatidiform 231090 614293 
236600,615219,307000,	Hydrocephalus aqueductal stenosis 236600 nonsyndromic pseudoobstruction recessive with autosomal 307000 disease 2 idiopathic intestinal due Hirschsprung 615219 congenital to 
260920,	Hyper-IgD 260920 syndrome 
147060,243700,	Hyper-IgE recurrent syndrome recessive 147060 autosomal infection 243700 
613677,617027,	613677 III IV 617027 Hyperaldosteronism type familial 
237900,237450,	neonatal transient 237900 Rotor type familial Hyperbilirubinemia digenic 237450 
143880,616963,	616963 1 2 Hypercalcemia 143880 infantile 
607748,	Hypercholanemia 607748 familial 
144010,603776,603813,143890,	{Hypercholesterolemia B apo {Low lipoprotein cholesterol 603813 3 to} autosomal modifier familial 144010 of} recessive QTL 1} LDLR to due density defect 143890 603776 ligand-defective Hypercholesterolemia susceptibility level 
144650,	Hyperchylomicronemia 144650 late-onset 
149400,614619,614618,	149400 dominant recessive 3 autosomal 2 614619 1 Hyperekplexia hereditary 614618 or 
607685,	syndrome resistant imatinib idiopathic 607685 to Hypereosinophilic 
600886,	Hyperferritinemia-cataract 600886 syndrome 
614462,138500,	138500 614462 and acidosis Hyperglycinuria lactic Hyperglycinemia seizures 
170500,613345,170400,	1 Hyperkalemic type 2 613345 periodic 170400 Hypokalemic paralysis 170500 
615947,617347,207750,	615947 617347 III Ib 1D 207750 type Hyperlipoproteinemia 
617013,613280,	dystonia 613280 617013 2 1 with Hypermanganesemia 
613752,614300,250850,	of adenosine with or deficiency I 250850 dominant methionine autosomal adenosyltransferase Methionine kinase 614300 hydrolase persistent Hypermethioninemia recessive to 613752 due III S-adenosylhomocysteine 
259900,613616,260000,	613616 260000 III primary 259900 Hyperoxaluria type 1 II 
145001,145000,239200,617343,	neonatal Hyperparathyroidism-jaw 145000 tumor primary syndrome Hyperparathyroidism 239200 familial 617343 145001 4 
233910,261630,264070,261640,617384,	mild B A BH4-deficient D 261630 264070 261640 C non-BH4-deficient Hyperphenylalaninemia 233910 617384 
614207,616809,614749,615716,239300,	1 614207 retardation 616809 syndrome 3 2 614749 Hyperphosphatasia 239300 mental 615716 6 with 4 
145250,	without hypopigmentation Hyperpigmentation with 145250 or 
616214,	Hyperproinsulinemia 616214 
239500,239510,	I Hyperprolinemia 239510 type II 239500 
112410,608622,189800,145500,605115,125853,	salt-sensitive} exacerbation brachydactyly and pregnancy-induced} early-onset pregnancy with essential insulin resistance syndrome dominant 189800 to} autosomal Hypertension 608622 145500 {Hypertension in 125853 essential} diastolic 112410 resistance-related salt-sensitive 605115 susceptibility 
603373,609152,	603373 gestational nonautoimmune 609152 familial Hyperthyroidism 
239850,	Hypertrichotic osteochondrodysplasia 239850 
145750,614480,	transient 614480 to} Hypertriglyceridemia susceptibility 145750 infantile {Hypertriglyceridemia 
614441,259100,	1 259100 primary 614441 recessive autosomal 2 Hypertrophic Cranioosteoarthropathy osteoarthropathy 
162000,613092,617056,	Hyperuricemic juvenile nephropathy 162000 2 613092 familial 617056 1 4 
610600,203400,	I CMO 610600 203400 to II congenital due Hypoaldosteronism deficiency 
604091,	Hypoalphalipoproteinemia 604091 
605019,615558,	Hypobetalipoproteinemia 615558 605019 2 familial 
601198,615361,	Hypocalcemia Bartter syndrome dominant 615361 autosomal 2 with 601198 
145980,600740,145981,	I hypercalcemia III Hypocalciuric type 145980 II 600740 145981 
146000,	Hypochondroplasia 146000 
240800,	of infancy Hypoglycemia 240800 leucine-sensitive 
612702,614839,615267,614837,616030,615271,146110,244200,614840,615270,147950,308700,614897,228300,615266,614858,612370,610628,614880,614838,615269,229070,	without 612702 19 614839 615267 614837 8 with or 10 616030 9 615271 7 syndrome 23 146110 3 244200 24 614840 anosmia 1 615270 6 308700 147950 614897 228300 1) 5 14 (Kallmann 615266 hypogonadism 614858 {Hypogonadotropic 22 612370 610628 16 Hypogonadotropic 11 15 614880 17 18 614838 2 615269 20 229070 anosmia} 21 4 
240900,	240900 hypoglycemia hemihypertrophy with Hypoinsulinemic 
602014,154020,611718,248190,248250,616418,613882,	611718 and renal intestinal 248250 with 154020 retardation 3 6 248190 1 5 ocular 602014 Hypomagnesemia mental 616418 involvement 2 4 seizures 613882 
146200,146255,	146200 146255 deafness dominant isolated recessive autosomal and renal sensorineural Hypoparathyroidism familial dysplasia 
241410,	Hypoparathyroidism-retardation-dysmorphism 241410 syndrome 
300554,613312,307800,241520,241530,193100,	AR rickets 300554 dominant recessive autosomal Hypophosphatemic hypercalciuria 2 613312 X-linked 307800 241520 with 241530 193100 
614435,241550,	syndrome left 241550 2 1 614435 Hypoplastic heart 
188740,	aplastic 188740 tibia polydactyly Hypoplastic with or 
613679,	Hypoprothrombinemia Dysprothrombinemia 613679 
300758,300633,	300633 Hypospadias 2 300758 X-linked 1 
616816,616801,615419,616900,	psychomotor 616816 1 retardation 616900 3 615419 and Hypotonia 616801 2 infantile characteristic facies with 
601553,146520,604379,607903,278150,607823,605389,137940,146550,615885,615059,	601553 604379 8 with macular 12 7 syndrome 607903 278150 Hypotrichosis-lymphedema-telangiectasia-renal dystrophy 605389 137940 6 1 615885 146550 congenital 146520 juvenile Hypotrichosis-lymphedema-telangiectasia 607823 615059 defect 11 2 Hypotrichosis 4 
612076,220150,	612076 serum {Uric acid concentration renal QTL 2 2} Hypouricemia 220150 
602540,	deafness Hystrix-like ichthyosis with 602540 
308205,	IFAP without syndrome 308205 BRESHECK with or 
614732,	614732 IMAGE syndrome 
607676,	607676 IRAK4 deficiency 
147750,	147750 IVIC syndrome 
607626,604777,601277,617574,607602,612281,613943,609165,617571,242500,615023,606545,617320,602400,242300,308100,146590,608649,146700,615024,242100,614457,146800,	of prematurity (harlequin) and 604777 607626 Ichthyosis 601277 617574 quadriplegia 8 with sclerosing 612281 607602 vacuoles 10 Curth-Macklin 12 9 retardation cyclic syndrome 613943 3 alopecia autosomal epidermolytic vulgaris 609165 617571 242500 1 6 615023 606545 congenital histrix Siemens 617320 5 leukocyte 14 4B 602400 recessive 242300 X-linked mental bullosa spastic 308100 11 146590 608649 146700 615024 242100 614457 type 2 confetti hyperkeratosis cholangitis 4A 13 146800 
242600,	242600 Iminoglycinuria digenic 
613953,616873,616636,308230,613496,613860,612783,616622,300645,300853,616576,613179,615207,300636,615707,615592,614894,613494,615978,209950,616433,614889,605258,610798,613796,607594,300584,606843,613495,615966,615607,611521,241600,269840,615617,614699,615206,240500,614891,615387,616005,617744,613493,606367,614893,300972,615577,617638,615468,615816,615897,615615,616126,614890,608106,616740,615401,615513,614700,614172,612782,614162,300988,617514,614892,	613496 MAPBP-interacting gamma 51 8 52 31C 615207 TCR-alpha 614894 613494 autosomal 209950 30 607594 6 615966 611521 38 269840 34 14 primary 240500 614891 31B mycobacterial 615387 delay 615577 615816 deficient defect Epstein-Barr 15 42 isolated atopic 2 developmental 614172 27B 13 613953 616636 308230 19 11A and 40 616576 12 613179 9 35 47 615592 23 3 615978 616433 614889 610798 613796 43 241600 mycobacteriosis abnormalities variable dermatitis 28 infection 26 614893 617638 AR 615897 616126 type 20 614892 without 31A 612783 46 IL21R-related ficolin 44 300645 IgM with deficiency 300636 615707 7 605258 24 variant magnesium hypohomocysteinemia lymphoproliferation autoimmunity phosphorylase purine 615617 cell SCID viral 617744 613493 29 due to 300972 615468 32A 615615 18 614890 608106 616740 615513 612782 21 nucleoside 300988 617514 616873 Immunodeficiency 613860 27A 32B 616622 300853 or 10 monocyte dominant hyper-IgM 50 48 common 300584 33 606843 36 1 613495 protein 615607 5 AD 615206 beta infections recessive 614699 in virus 616005 41 X-linked 606367 neoplasia 11B dendritic 17 CD3 neurologic 615401 614700 614162 4 hyper 
242860,616911,616910,614069,	anomalies Immunodeficiency-centromeric syndrome syndrome-2 616911 3 614069 616910 1 242860 4 instability-facial 
304790,	polyendocrinopathy and enteropathy 304790 X-linked Immunodysregulation 
609529,	A Immunoglobulin 609529 2 deficiency 
167320,	myopathy Inclusion and 167320 disease Paget early-onset 1 dementia body with frontotemporal 
308300,	Incontinentia 308300 pigmenti 
616483,	syndrome Infantile 2 616483 failure liver 
256600,	neuroaxonal 256600 dystrophy Infantile 1 
612261,612567,612245,612244,611081,613148,266600,612278,	disease-associated 612244 611081 10} 266600 growth Crohn 612261 autosomal onset 14} failure} disease} 1 Inflammatory protection {Inflammatory (Crohn 612567 early 25 recessive disease 613148 28 against} 19} 612245 17 bowel {Crohn 13} 612278 disease) 
256800,243000,	pain anhidrosis recessive with autosomal HSAN2D 256800 243000 congenital to Insensitivity 
600072,	600072 Insomnia familial fatal 
617173,617532,617450,617333,617452,	617532 difficulties and cardiac facies 617333 with 617173 617452 high anomalies dysmorphic neuropsychiatric distal ptosis 617450 disorder pain limb gastrointestinal arrhythmia threshold developmental Intellectual features seizures 
612852,	antagonist Interleukin 612852 1 receptor deficiency 
615486,614748,	epidermolysis syndrome lung 615486 and nephrotic disease Interstitial 614748 congenital bullosa liver 
300640,610799,	pneumococcal against} recurrent isolated 300640 610799 invasive disease {Pneumococcal 2 1 protection Invasive 
123150,	Jackson-Weiss 123150 syndrome 
251255,	251255 Jawad syndrome 
220400,612347,	220400 612347 Jervell syndrome and 2 Lange-Nielsen 
614465,614424,616490,614464,612285,616654,608091,614970,200990,617120,612291,617622,300804,616781,611560,615636,614173,617757,617761,610688,614615,609583,213300,608629,617767,614175,610188,617121,614815,614844,	614465 614424 19 616490 614464 8 10 12 612285 9 616654 7 syndrome 23 3 24 4 608091 614970 30 200990 617120 33 1 6 612291 617622 300804 27 14 34 5 25 616781 611560 615636 614173 617757 16 Joubert 28 617761 610688 614615 609583 213300 608629 15 617767 17 32 18 614175 31 610188 2 20 21 617121 614815 614844 Acrocallosal 13 
610069,175050,174900,	175050 syndrome 174900 hemorrhagic juvenile polyposis form 2 610069 Juvenile infantile telangiectasia intestinal Polyposis hereditary mixed or 
300867,147920,	147920 syndrome 300867 2 1 Kabuki 
612713,	Kahrizi 612713 syndrome 
609242,	disease 609242 Kanzaki 
244460,127000,	127000 syndrome 244460 Kenny-Caffey type 2 1 
148190,	Keratitis 148190 
148210,	148210 syndrome Keratitis-ichthyosis-deafness 
148600,148350,	148600 deafness 148350 IA type punctate palmoplantar with Keratoderma 
601952,308800,612908,607654,148700,182000,	congenita spinulosa and 148700 with sclerosing I 607654 182000 601952 308800 palmoplantaris AD Keratosis somatic X-linked keratoderma II seborrheic linearis III decalvans striata follicularis 612908 ichthyosis 
601887,145600,	{Malignant 5} syndrome King-Denborough hyperthermia 1} susceptibility 601887 145600 
610253,617768,	Kleefstra syndrome 610253 2 1 617768 
214300,613702,118100,616549,	myopathy Klippel-Feil syndrome dominant 214300 3 autosomal recessive and dysmorphism 2 613702 118100 1 with 4 facial 616549 
156550,	156550 dysplasia Kniest 
616592,	616592 overgrowth Kosaki syndrome 
262650,	Kowarski 262650 syndrome 
611722,245200,	611722 atypical disease 245200 Krabbe 
606693,	syndrome 606693 Kufor-Rakeb 
615604,	L-ferritin dominant recessive and 615604 deficiency 
149730,	LADD 149730 syndrome 
143890,	cholesterol 143890 QTL2 LDL level 
613707,611554,151100,	LEOPARD syndrome 3 611554 151100 2 1 613707 
606593,	syndrome 606593 LIG4 
223000,223100,	223000 223100 nonpersistence persistence Lactase congenital or deficiency 
245349,	245349 Lacticacidemia to due PDX1 deficiency 
160500,	distal myopathy Laing 160500 
249700,	dysplasia Langer mesomelic 249700 
617182,	Language without cognitive arrhythmia and cardiac ADHD impairment 617182 with delay or 
262500,	Laron 262500 dwarfism 
150250,	150250 syndrome Larsen 
245660,	245660 Laryngoonychocutaneous syndrome 
130720,	meningocele 130720 Lateral syndrome 
135750,	135750 Laurin-Sandrow syndrome 
204000,204100,611755,613829,615360,613843,608553,613341,613837,613835,610612,613826,608133,604232,604537,614186,612712,	8 608133 604537 615360 10 12 9 7 611755 3 613835 610612 1 6 613826 congenital 604232 613829 5 14 amaurosis 613843 608553 613341 16 13 204000 11 15 17 Leber 18 613837 2 204100 614186 612712 
604169,615092,601494,615373,611878,601493,615396,613424,613426,	without 604169 615092 611878 Left 8 with or 10 9 7 3 ventricular 615373 defects 6 1 congenital 613424 5 noncompaction 601494 heart 601493 615396 4 613426 
150600,	disease Legg-Calve-Perthes 150600 
256000,220111,	I 1 oxidase IV syndrome 256000 complex 220111 Leigh mitochondrial COX4 type French-Canadian c to COX cytochrome due deficiency 
150800,	cell and cancer renal Leiomyomatosis 150800 
246200,	Leprechaunism 246200 
127300,	127300 Leri-Weill dyschondrosteosis 
300322,	Lesch-Nyhan 300322 syndrome 
617194,607598,615368,611369,253310,616286,616503,614915,617022,	617194 contracture 616503 614915 10 9 7 syndrome 3 Lethal 1 congenital 5 607598 611369 contractural 616286 11 2 253310 4 615368 617022 
601626,613065,608232,new39,615545,612376,190685,607785,102578,	without post-chemotherapy, myeloid} {Leukemia, leukemia leukemia} B-cell Myelogenous T-cell reduced with Down or Lymphocytic Megakaryoblastic promyelocytic PL2F/RARA 601626 chronic syndrome to} lymphoblastic Leukemia 615545 imatinib PML/RARA {T-cell survival 3} myelomonocytic acute lymphoma leukemia, juvenile myeloid somatic in 612376 190685 chromosome-positive to {Leukemia 102578 prolymphocytic lymphocytic resistant 613065 608232 megakaryoblastic type 2 susceptibility Philadelphia 607785 
612840,116920,	612840 III 116920 Leukocyte type adhesion deficiency 
616683,610532,612438,612233,607694,614381,260600,616763,616140,616420,169500,616881,616494,608804,	without adult-onset 614381 and 616140 8 with 616881 or 10 12 microcephaly 9 7 dominant 3 autosomal 616763 acquired 169500 616420 6 607694 616494 608804 616683 610532 hypomyelinating 5 hypogonadotropic hypogonadism oligodontia 612233 dystonia 612438 11 260600 2 Leukodystrophy 4 13 
615651,221820,611105,603896,614561,615889,612951,	cystic without 615651 ataxia matter and Leukoencephalopathy diffuse progressive spinal with white 221820 elevation brain 615889 failure megalencephaly lactate 611105 603896 ovarian cord 612951 spheroids stem involvement calcifications 614561 vanishing hereditary cysts 
238320,	238320 resistance cell hypoplasia hypergonadotropic Luteinizing Leydig pseudohermaphroditism hypogonadism hormone female with 
609265,151623,	Li-Fraumeni 609265 151623 syndrome 
177200,	177200 Liddle syndrome 
603543,	Limb-mammary 603543 syndrome 
300952,300887,309801,	skin anomalies 309801 Linear 3 multiple 2 defects 300952 1 with congenital 300887 
608709,604367,615980,269700,608594,613877,613327,151660,	615980 269700 608594 613327 {Lipodystrophy Lipodystrophy 3 to} familial acquired 6 1 congenital 613877 partial generalized 608709 604367 type 2 susceptibility 151660 4 
125853,604367,	resistance {Insulin 604367 to} Insulin 125853 severe susceptibility digenic 
611771,	611771 Lipoprotein glomerulopathy 
238600,	lipase 238600 Lipoprotein deficiency 
617255,615191,607432,257320,300215,611603,616212,300067,614019,	abnormal genitalia 611603 8 with heterotopia microcephaly Subcortical 615191 3 300215 300067 6 1 laminar (Norman-Roberts (with 5 type) 607432 X-linked 614019 Lissencephaly laminal 617255 microcephaly) 257320 616212 2 Hydranencephaly 4 
613070,	613070 transient infantile failure Liver 
610168,609192,613795,615582,614816,	610168 5 609192 syndrome 3 613795 Loeys-Dietz 2 615582 614816 1 4 
613688,613695,612955,613693,192500,611819,611818,613485,600919,616249,616247,603830,	Long 612955 QT 613693 611818 613485 613695 reduced 12 9 syndrome to} acquired 1 600919 6 syndrome-3 5 14 ankyrin-B-related 616249 {Long 616247 603830 613688 15 arrhythmia 192500 syndrome-10 611819 2 susceptibility 4 13 Cardiac 
617435,	Lopes-Maciel-Rodan 617435 syndrome 
309000,	Lowe 309000 syndrome 
309520,	309520 Lujan-Fryns syndrome 
new72,182280,211980,new51,	smokers} of cancer Adenocarcinoma 182280 211980 resistance inhibitor lung to} kinase response protection {Nonsmall the {Lung cell tyrosine Small somatic in cancer, to against} susceptibility Nonsmall against, Lung 
606690,	606690 Lymphangioleiomyomatosis somatic 
153400,613480,153100,616843,615907,	ID 153400 III Lymphedema 153100 613480 616843 syndrome with IA and renal diabetes 615907 IC disease Lymphedema-distichiasis mellitus hereditary 
605027,236000,new11,new41,113970,137245,	Lymphoma B-cell somatic} 137245 non-Hodgkin, non-Hodgkin MALT to} high-grade {Lymphoma 113970 605027 lymphoma follicular 236000 somatic mantle {Hodgkin Burkitt Lymphoma, susceptibility cell, 
615122,300635,613011,308240,	300635 syndrome 308240 615122 2 Lymphoproliferative 613011 X-linked 1 
303350,	MASA 303350 CRASH syndrome 
604308,	604308 MASS syndrome 
300960,	MEND 300960 syndrome 
617053,	MIRAGE 617053 syndrome 
600496,125851,606392,125850,	I III IV 600496 type 125851 MODY II 606392 125850 
248000,614192,617011,613075,605309,	Macrocephaly and macrosomia facies or psychomotor retardation 614192 syndrome dysmorphism alopecia autosomal megalencephaly 248000 dysmorphic laxa 617011 recessive cutis autism 613075 605309 facial scoliosis 
153600,	somatic 153600 Macroglobulinemia Waldenstrom 
613112,600208,	TUBB1-related deafness dominant 613112 autosomal and sensorineural 600208 progressive Macrothrombocytopenia 
615489,153800,610698,611953,611378,248200,603075,615439,615591,610149,613761,613784,613778,300834,616118,608895,	degeneration 610698 611953 615439 early-onset type} reduced risk 615489 3 to} 9} 248200 atrophic {Macular 11} 615591 neovascular 613778 Macular 153800 5} 14 8} juvenile of} 12} 1} 603075 X-linked 613761 613784 616118 to 15 2} age-related 611378 4} 610149 susceptibility 7} 300834 13 608895 
616152,608970,217800,608161,608051,169150,153700,616151,136550,616170,	Carolina cone 136550 North with 616170 vitelliform corneal 608161 3 dystrophy 1 patterned Macular central 5 retinal 217800 608970 608051 169150 616151 616152 involvement 153700 type 2 4 
155755,601800,155601,155600,613099,615134,615848,614456,new42,613972,609048,	6} Melanoma 613099 10} and Melanoma, 614456 neural malignant, syndrome 615134 cutaneous 9} melanoma 3} 613972 5} 155601 8} 155600 system somatic to 155755 601800 tumor 615848 susceptibility Malignant 609048 2} {Melanoma malignant 
212112,	Malouf 212112 syndrome 
615381,	deafness syndrome Mandibular hypoplasia 615381 and lipodystrophy features progeroid 
608612,248370,	608612 B 248370 Mandibuloacral lipodystrophy type with dysplasia 
610536,616367,	Guion-Almeida Mandibulofacial alopecia type 610536 dysostosis with 616367 
248450,	oculotrichoanal syndrome 248450 Manitoba 
248500,248510,	I types beta and alpha- Mannosidosis 248500 248510 II 
248600,	Ia Ib urine disease syrup type Maple II 248600 
154700,616914,	154700 616914 syndrome lipodystrophy Marfan 
154780,	Marshall 154780 syndrome 
602535,	602535 Marshall-Smith syndrome 
212720,	Martsolf 212720 syndrome 
154800,	disease Mast 154800 cell 
155100,	May-Hegglin 155100 anomaly 
174800,	mosaic 174800 syndrome somatic McCune-Albright 
236700,	syndrome 236700 McKusick-Kaufman 
608978,	Meacham 608978 syndrome 
603194,249000,615397,612284,611134,607361,617562,611561,267010,	603194 249000 5 11 615397 syndrome 612284 611134 3 607361 Meckel 7 2 617562 611561 6 1 267010 4 13 
614665,	614665 Meconium ileus 
174000,603860,	cystic disease Medullary 2 1 174000 603860 kidney 
122100,	dystrophy 122100 corneal Meesmann 
300989,	300989 Meester-Loeys syndrome 
613925,613926,604004,	2A Megalencephalic without remitting retardation subcortical 613925 613926 604004 mental with leukoencephalopathy cysts or 2B 
602501,	Megalencephaly-capillary syndrome malformation-polymicrogyria somatic 602501 
603387,615938,615937,	615938 syndrome 3 Megalencephaly-polymicrogyria-polydactyly-hydrocephalus 2 1 603387 615937 
613839,261100,	Finnish Norwegian dihydrofolate Megaloblastic 261100 reductase type anemia 613839 to due anemia-1 deficiency 
613800,617063,616835,613804,613803,224690,	Meier-Gorlin 613800 7 syndrome 617063 3 616835 4 613803 613804 2 6 1 224690 
137550,	Melanocytic syndrome 137550 spilus somatic {Spitz somatic} congenital nevus or 
309350,	Melnick-Needles 309350 syndrome 
607174,	Meningioma {Meningioma} to} somatic 607174 {Meningioma susceptibility familial NF2-related SIS-related 
309400,	disease Menkes 309400 
300997,300423,249500,611090,300659,300271,612580,614340,616078,614499,300558,300495,616521,615502,616393,607417,300210,300982,617601,615942,617270,300998,616193,616917,617028,300850,615802,300055,300676,613671,613670,136630,615541,300749,617635,300957,614104,613970,300263,300143,615761,616973,615286,300984,305400,300243,616944,300706,614020,616083,300802,617600,617125,300919,300860,616977,304340,309580,614255,615074,614254,309549,612337,616268,614249,613443,300436,300799,612621,608443,300986,309530,615866,612581,615075,300849,300958,617752,300422,300803,300387,616351,617751,300123,616579,615516,611091,617432,616355,300699,610156,613192,614563,617323,616116,615637,309541,300966,615834,300114,300968,156200,300967,300987,617188,615599,300486,309548,617061,614202,300419,616158,309583,616269,615828,616362,300983,300260,616739,300844,616311,616789,611093,300354,611092,617773,300978,300912,616281,300534,	 300997 300423 249500 stereotypic 611090 51 300659 300271 FRAXE malformations facies 8 growth 612580 614340 obesity nystagmus retardation-hypotonic retardation 616078 autosomal dystrophy 30 614499 6 59 Nascimento-type 300558 38 60 34 Hedera Turner 14 type) 300495 pontine 616521 53 Snyder-Robinson (Cabezas 615502 616393 607417 female-restricted 300210 impairment micropenis 300982 617601 615942 15 isolated syndromic 42 movements 617270 FRA12A 300998 616193 2 616917 hormone 617028 epilepsy 300850 615802 Siderius 103 features 13 truncal 300055 300676 19 613671 613670 strabismus and 136630 615541 300749 40 617635 99 cerebral 300957 614104 12 microcephaly 61 9 35 47 appearance 23 3 lissencephaly acidemia 613970 ) 43 language Claes-Jensen 300263 300143 615761 616973 615286 90 Christianson Lubs Aarskog-Scott 300984 16 26 305400 300243 616944 300706 hypoplasia 616083 614020 54 300802 31 617600 type 617125 98 300919 300860 without 304340 616977 58 maxillary 615074 others 104 614254 614255 309580 46 309549 612337 cardiac 44 616268 with 614249 78 613443 protrusion deficiency 300436 7 45 300799 612621 24 608443 300986 variant defects 309530 615866 72 612581 615075 105 300849 300958 27 retinal 617752 Mental 300422 49 300803 300387 distinctive 94 29 cerebellar 22 Raymond 616351 63 617751 300123 102 616579 18 615516 611091 617432 616355 300699 610156 21 613192 614563 facial 57 617323 616116 autistic 615637 309541 300966 615834 300114 300968 156200 homocysteinemia (methylmalonic 300967 300987 617188 615599 or 300486 309548 617061 97 syndrome 300419 dominant 48 614202 33 616158 309583 1 36 616269 615828 616362 300983 300260 5 616739 recessive 96 300844 616311 41 616789 X-linked 56 anterior Bain 611093 cblX 106 300354 32 39 611092 93 617773 Borck 300978 300912 616281 300534 4 
609535,	Mephenytoin metabolizer 609535 poor 
156240,	{Mesothelioma somatic 156240 somatic} Mesothelioma 
156250,	156250 Metachondromatosis 
249900,250100,	deficiency 250100 SAP-b 249900 due leukodystrophy to Metachromatic 
250400,602111,613073,156510,250460,156530,156500,156400,	hypotrichosis without maxillary brachydactyly Spahr 602111 250400 with or anadysplasia Jansen 1 Schmid 156530 dysplasia 156400 Murk Metatropic chondrodysplasia 250460 156500 hypoplasia type 2 613073 156510 Metaphyseal 
277410,613646,251100,614857,251000,277400,277380,251110,	of and cblB 614857 cblC vitamin mut(0) adenosylcobalamin cblF 251100 variant 277380 B12-responsive cblJ transcobalamin 613646 synthesis in 251110 receptor to due cblD aciduria defect 277410 transient homocystinuria type 2 277400 251000 complementation Methylmalonic 
610377,	610377 aciduria Mevalonic 
210720,210710,	Microcephalic I dwarfism 210710 210720 osteodysplastic type II primordial 
251270,613668,617604,612703,616335,614261,614852,604317,604804,607196,604321,616486,251200,617090,608393,614673,615760,614833,616817,613402,251230,616033,152950,616834,616171,614231,605622,608716,	251270 without Amish 613668 617604 612703 and malformations 616335 progressive 8 with 614261 cerebral or atrophy 614852 seizures impaired 9 7 retardation syndrome malformation 3 autosomal 604317 Microcephaly 604804 brain chorioretinopathy Microcephaly-capillary 1 6 polymicrogyria congenital 607196 604321 616486 5 abnormalities primary 251200 recessive 617090 diabetes 608393 dermatitis Microcephaly-micromelia 614673 cerebellar 615760 lymphedema mental delay calcification 616817 613402 614833 251230 616033 psoriasiform cortical metabolism 152950 15 limb short 17 stature 616834 spasticity epilepsy type 2 616171 614231 postnatal developmental 605622 cataract 4 glucose 608716 
193220,615458,	telecanthus 615458 Vitreoretinochoroidopathy chorioretinal myopic staphyloma and Microcornea dystrophy 193220 posterior rod-cone cataract atrophy 
611038,610125,615145,206900,616428,615113,615877,610092,613704,607932,613094,614497,601186,300166,613517,610093,611040,615524,611638,206920,613703,	611038 610125 of 615145 206900 616428 and 615113 Microphthalmia nervous 615877 8 with 610092 613704 or 10 607932 613094 12 coloboma 9 7 skeletal syndrome 3 Optic 614497 6 dysplasia 601186 digenic the anomalies central 5 300166 abnormalities 613517 610093 611040 system 615524 limb isolated syndromic 611638 hypoplasia nerve 206920 613703 2 4 
251750,	without glaucoma megalocornea ectopia lentis 251750 and secondary Microspherophakia with or 
602481,609634,141500,613656,157300,	without ataxia progressive with or 602481 resistance 3 to} 613656 Migraine familial 1 157300 609634 basilar cerebellar aura to 141500 13} 2 hemiplegic susceptibility {Migraine 
255320,	myopathy ophthalmoplegia external Minicore 255320 with 
157600,614508,	614508 callosum of movements agenesis corpus and Mirror 2 157600 1 or the 
276300,	syndrome repair Mismatch cancer 276300 
613662,612075,603041,256810,615418,609560,251880,617184,271245,245400,203700,615084,612073,615471,	without (myopathic 615418 renal (MNGIE with or 612075 9 7 syndrome 3 256810 245400 1 6 DNA 8A (cardiomyopathic (hepatocerebral 612073 8B aciduria) 5 type) 603041 AD (Alpers 4B 251880 617184 depletion 271245 tubulopathy) 203700 Mitochondrial AR 613662 12A 11 12B methylmalonic 609560 type 2 (encephalomyopathic 615084 4A 13 615471 
220110,615158,611126,124000,615159,252011,615838,615157,615453,252010,614052,615160,	220110 615158 124000 252011 615838 V 8 615160 deficiency I 611126 3 615157 1 6 252010 nuclear 5 615159 chain respiratory 615453 II synthase) Mitochondrial to due ACAD9 III IV (ATP complex type 2 614052 4 
607459,	SCAE) ataxia syndrome (includes recessive and 607459 SANDO Mitochondrial 
607829,	607829 prolapse valve 2 Mitral 
254130,613319,	muscular 613319 Miyoshi 3 dystrophy 254130 1 
252150,615501,252160,	B A cofactor 252150 252160 C 615501 Molybdenum deficiency 
158000,	158000 Monilethrix 
616095,	transporter 616095 Monocarboxylate 1 deficiency 
617598,257300,614114,	617598 aneuploidy syndrome 3 257300 2 1 Mosaic variegated 614114 
615750,607151,614042,	achalasia 5 Moyamoya 615750 to} {Moyamoya disease 2 susceptibility 6 with 607151 614042 
191900,	Muckle-Wells 191900 syndrome 
252600,252605,252650,252500,	alpha 252600 III IV 252650 beta Mucolipidosis gamma 252605 252500 II or 
607014,309900,607016,617303,252940,607015,253220,252920,253000,253200,253010,252930,252900,	Is s IVA 607015 IIID 253220 252920 253000 IVB IIIA 253200 or 607016 syndrome IIIC IIIB 252900 617303 A) Mucopolysaccharidosis 607014 309900 C) 252940 253010 II (Maroteaux-Lamy) (Morquio) Mucopolysaccharidosis-plus (Sanfilippo B) Ih VI type 252930 VII 
602849,	syndrome 602849 Muenke 
158320,	Muir-Torre 158320 syndrome 
166300,	166300 syndrome osteolysis carpotarsal Multicentric 
615398,614080,300868,	614080 syndrome 615398 Multiple 3 2 1 congenital anomalies-hypotonia-seizures 300868 
171400,131100,610755,162300,	171400 IV IIA Multiple 610755 162300 type 1 IIB neoplasia 131100 endocrine 
617613,616370,614299,605711,	617613 616370 5 dysfunctions syndrome Multiple mitochondrial 2 1 hyperglycinemia with 614299 4 605711 
253290,	syndrome Multiple lethal pterygium type 253290 
612961,186500,610017,	synostoses syndrome Multiple 3 2 612961 186500 1 610017 
613834,	smooth Multisystemic muscle syndrome 613834 dysfunction 
614160,300559,	614160 300559 hypertrophy glycogenosis Muscle 
611307,613158,608807,253280,613153,611588,617404,607155,608840,614830,253600,607801,253700,613156,602771,613151,602541,254110,603511,613723,615181,616538,613818,613155,615041,615350,615287,253601,615249,615352,601954,613154,159001,159000,608099,613157,609308,609115,236670,604286,606612,613205,607855,615356,615351,616827,613150,616052,253800,608423,613204,613152,601287,614643,	607155 8 613156 613151 602541 dystrophy 613155 2D 6 2G anomalies disability 14 2E 2S spine 2W 159000 604286 2 253800 614643 13 2B B 613153 611588 617404 and 608840 12 9 602771 254110 3 603511 613723 (limb-girdle) 616538 brain 615350 2Q 2C (congenital 2F 601954 1A merosin-deficient A 11 1B type IC 613150 608423 611307 without 614830 253600 with 607801 deficiency 2A 2J 7 1E retardation) 615041 615287 2L 253601 615249 Muscular LAMA2 1G mental to due limb-girdle 159001 608099 cataracts 236670 609115 anomalies) 606612 615356 616827 eye 613204 613152 613158 608807 intellectual 253280 2H or 253700 10 615181 613818 1F 1 congenital 5 megaconial C 615352 613154 rigid dystrophy-dystroglycanopathy partial 613157 609308 613205 ITGA7 607855 615351 616052 601287 4 
615120,616228,616720,616040,614198,614750,617239,605809,254210,616325,608931,608930,616326,616324,603034,254300,616322,616313,601462,617143,	Myasthenic presynaptic 616720 19 616325 3B and pre- 616324 aggregates 254300 616322 with 601462 617239 616313 8 deficiency 10 2A 615120 9 7 616040 syndrome 614750 605809 616326 fast-channel 603034 defects 6 congenital 617143 616228 5 tubular 14 614198 4B associated 608931 receptor 16 1A acetylcholine slow-channel 11 254210 1B postsynaptic 608930 20 21 4C 4A 13 
614286,	614286 syndrome Myelodysplastic to} somatic susceptibility {Myelodysplastic 
254450,	metaplasia Myelofibrosis myeloid somatic 254450 with 
254600,	Myeloperoxidase 254600 deficiency 
139210,	Myhre 139210 syndrome 
616421,254770,605021,	616421 254770 juvenile {Myoclonic epilepsy Myoclonic 1} Myoclonic-atonic familial infantile 605021 susceptibility to 
614937,617235,	neonatal cortical 617235 Myoclonus 614937 familial intractable 
228550,	228550 Myofibromatosis infantile 1 
617675,617158,617030,613076,609452,603689,614065,615673,255160,182920,601419,608358,160565,600462,608810,606768,255310,609524,615883,612954,614399,310440,616231,613561,615511,613869,609200,255125,617258,617114,614321,	617158 areflexia anemia 255160 8 vacuoles 608358 autosomal mitochondrial 6 loss fiber-type muscle 616231 613561 delay hypertonic 609200 2 614321 developmental autophagy cataract disproportion 613076 and early-onset alpha-B progressive crystallin-related Tateyama 600462 3 608810 606768 onset sideroblastic tubular distal 612954 dysphagia 310440 signs spheroid distress 255125 type 617258 hearing tibial extrapyramidal 609452 Myopathy 615673 body with 182920 deficiency 160565 7 variant lactic rimmed fatal proximal 255310 early 615883 respiratory due to involvement excessive 617114 hereditary myoadenylate 617675 ataxia 617030 603689 614065 aggregates 601419 deaminase dominant storage 1 vacuolar congenital mild 5 609524 CASQ1 myosin recessive 614399 615511 X-linked infantile anterior 613869 acidosis myofibrillar 4 aggregate 
615348,615731,605355,610687,256030,161800,609284,617336,616165,609285,609273,	myopathy excess Amish 615731 of 605355 Myopathy 609284 617336 609285 8 with or 10 9 7 dominant 3 autosomal 610687 609273 1 6 congenital thin 615348 5 recessive cores actin Nemaline 11 256030 161800 type 2 616165 myofilaments 4 
617238,615946,615420,614167,608908,614292,615431,	degeneration vitreoretinal and 608908 with 23 dominant autosomal 24 615946 617238 6 614292 high 25 recessive 615420 614167 22 Myopia 21 cataract 615431 
160900,602668,160800,255700,new49,608390,	congenita 160900 Myotonic Myotonia 602668 dominant 160800 recessive acetazolamide-responsive atypical 255700 dystrophy 2 1 levior, 608390 
255960,	255960 intracardiac Myxoma 
161000,	161000 Naegeli-Franceschetti-Jadassohn syndrome 
614157,151600,	nonsyndromic (leukonychia) 3 nails) 151600 disorder (claw-shaped 614157 congenital Nail 10 
302350,	302350 Nance-Horan syndrome 
615972,609549,	Nanophthalmos 615972 2 4 609549 
617075,607107,	carcinoma Nasopharyngeal 617075 607107 susceptibility 3} to {Nasopharyngeal 
221770,	disease Nasu-Hakola 221770 
601214,	Naxos disease 601214 
609284,609285,	myopathy CAP 2 609284 609285 1 
300539,	of syndrome Nephrogenic inappropriate antidiuresis 300539 
310468,605990,612287,612286,	I 1 Nephrolithiasis {Nephrolithiasis 612286 uric acid 612287 to} type 2 605990 susceptibility osteoporosis hypophosphatemic 310468 or 
613820,611498,609057,614196,613550,615573,616892,614377,615244,614845,617575,614199,600995,602088,614809,616217,617609,617783,256370,615382,615861,604387,615008,615862,616730,613159,606966,610725,256300,617271,256100,614844,	613820 611498 without 609057 19 pretibial 613550 nephropathy and 614196 616892 615573 614377 8 with or deficiency epidermolysis 12 10 614845 617575 7 614199 syndrome 600995 615244 602088 3 4 614809 CFHR5 616217 9 1 6 Nephropathy 617609 617783 256370 615382 615861 5 604387 Nephronophthisis-like 14 deafness juvenile ocular Nephronophthisis abnormalities 615008 615862 616730 613159 606966 infantile 610725 16 due to bullosa 11 15 18 Nephrotic type 2 256300 20 617271 256100 614844 13 
612926,612922,612924,615008,612923,235400,612925,	612926 6} syndrome to} atypical 3} uremic 612925 612922 5} 615008 1} 235400 to {Hemolytic 612924 612923 4} susceptibility 7} 2} 
256520,616038,	616038 syndrome 256520 Neu-Laxova 2 1 
601634,182940,	tube Neural {Spina {Neural to} bifida susceptibility defects folate-sensitive 601634 182940 
613013,613014,256700,	Neuroblastoma 256700 {Neuroblastoma 613013 613014 1} disease susceptibility 3} Hirschsprung with 2} to 
249400,	Neurocutaneous melanosis somatic 249400 
617672,300894,234200,614298,617145,613068,610217,606159,615643,	ataxia transport 614298 and gaze accumulation 613068 with 615643 cerebral atrophy deficiency 300894 3 childhood-onset 617145 brain 1 iron 6 folate 5 617672 234200 to due Neurodegeneration dystonia palsy 610217 606159 4 2B 
617481,617527,617393,617710,616975,617268,617755,617493,	without of abnormal difficulties and myelination facies hypotonia progressive with absent 617755 or 617268 617493 617527 microcephaly mitochondrial lactic 617710 feeding brain involuntary language the anomalies dysmorphic distal variable disorder delayed cataracts limb 617481 movements spasticity acidosis epilepsy Neurodevelopmental 617393 eye heart 616975 seizures 
101000,162200,162210,601321,	syndrome 101000 162210 Neurofibromatosis type 2 Neurofibromatosis-Noonan familial 1 spinal 162200 601321 
604320,615575,158580,617721,	604320 IX distal IID 615575 VIIA VI 617721 158580 type motor hereditary Neuronopathy 
613640,201300,616505,608654,616488,614116,613115,158590,600794,162400,613708,608634,162500,615548,607641,605285,614213,615632,256840,605253,608895,	without 613640 degeneration IIA 201300 616505 608654 IA and 616488 614116 613115 V with IE or macular 158590 VIIB 600794 motor 1 congenital 162400 autonomic 613708 608634 ID 162500 hypomyelinating recurrent distal palsies 615548 IF 607641 II IIB VIB Russe spastic sensory paraplegia 605285 IIC VA age-related 608895 type IC 614213 Neuropathy 615632 256840 VII 605253 hereditary pressure VIII 
202700,162800,new50,612541,615285,300299,617014,610738,616022,	612541 300299 616022 202700 7 cyclic syndrome dominant 3 Dursun autosomal severe alloimmune 610738 6 1 congenital Neutropenia neonatal 5 Neutropenia, recessive 615285 617014 X-linked 162800 4 
617025,	617025 Nevus somatic comedonicus 
162900,	Nevus 162900 sebaceous {Nevus somatic hair woolly epidermal somatic} Epidermal or nevus 
607476,	dystrophy Newfoundland rod-cone 607476 
257200,257220,607625,607616,	B A 257220 Niemann-pick 257200 D 607625 607616 disease Niemann-Pick type C2 C1 
613830,300071,614565,257270,617024,610445,610444,613216,163500,310500,615058,	300071 blindness 613216 (incomplete) 2A 1C 1D dominant 3 autosomal 257270 1E 614565 1H 1F 1 310500 congenital 613830 Night recessive stationary 610444 X-linked 163500 1A 1B (complete) 610445 2 type 617024 615058 
251260,613078,	251260 syndrome 613078 syndrome-like Nijmegen disorder breakage 
605820,	605820 myopathy Nonaka 
163950,613224,609942,615355,616559,616564,617506,610733,611553,613563,607721,613706,	without 615355 leukemia Noonan-like 617506 8 with or 607721 10 9 7 syndrome 3 Noonan 616559 syndrome-like anagen 6 1 613563 myelomonocytic 613706 163950 5 613224 609942 juvenile hair 616564 610733 disorder loose 2 611553 4 
310600,	310600 disease Norrie 
245900,	245900 disease Norum 
300814,310700,	Nystagmus 300814 periodic 310700 X-linked 6 1 infantile congenital alternating 
601665,613886,607447,new52,607514,300306,614962,609734,612362,600955,614963,602025,612460,	leptin 613886 diabetes} 607514 BMIQ4} and 300306 prohormone early-onset with impaired processing deficiency BMIQ12} in} {Obesity variation 607447 dominant to} autosomal 614962 609734 severe adrenal 612362 Obesity, insufficiency mild BMIQ9} association 601665 POMC hyperphagia, hair BMIQ11} Obesity with} morbid receptor II late-onset} delay to due red hyperphagia BMIQ14} type developmental 600955 susceptibility 614963 602025 612460 
304150,	syndrome 304150 Occipital horn 
300500,	I albinism type 300500 Nettleship-Falls Ocular 
257850,164200,	Oculodentodigital recessive 257850 autosomal 164200 dysplasia 
257980,	257980 dysplasia Odontoonychodermal 
613411,258100,	613411 Oguchi disease-2 258100 disease-1 
300895,	X-linked 300895 Ohdo syndrome 
608615,	Oligodontia-colorectal syndrome 608615 cancer 
275400,	syndrome 275400 Oliver-McFarlane 
603554,	603554 Omenn syndrome 
609535,	metabolizer 609535 poor Omeprazole 
617743,617712,616780,615774,	defect 617712 3 615774 617743 2 maturation 1 616780 4 Oocyte 
300000,145410,	I 300000 Opitz syndrome 145410 type GBBB II 
305450,	305450 Opitz-Kaveggia syndrome 
125250,616732,612989,165300,165500,610708,	without ataxia and with 610708 atrophy or 10 125250 retardation 7 syndrome 3 Optic 1 165500 5 165300 plus mental 616732 612989 cataract seizures 
165550,	hypoplasia 165550 nerve Optic 
129400,608864,225060,608874,613705,600625,	Rapp-Hodgkin 5 6} 11 7 129400 cleft syndrome 608864 225060 Orofacial 613705 608874 600625 8 {Orofacial 10 
277170,617563,258860,174300,311200,	I 277170 IV syndrome XVI Orofaciodigital VI 617563 258860 174300 V 311200 
166350,	Osseous heteroplasia 166350 progressive 
607850,165720,604864,612400,140600,	mild {Osteoarthritis 607850 {Osteoarthritis-5} 165720 604864 1} 612400 chondrodysplasia susceptibility 140600 3} with 2} Osteoarthritis 
613982,259420,615066,166220,166200,613848,614856,610967,610968,615220,610915,259440,166210,610682,616507,	IX 615066 610968 615220 V 610682 614856 I 259420 166220 613848 610967 Osteogenesis XIII 610915 259440 166210 imperfecta 613982 XI XV XVII II XIV 616507 III IV 166200 VI type VII X VIII 
166250,	Osteoglophonic dysplasia 166250 
174810,	174810 familial expansile Osteolysis 
259720,607634,611497,259730,612301,259710,611490,166600,615085,259700,	259720 Osteopetrosis renal 611490 615085 8 with 7 dominant 3 autosomal 259710 6 1 259700 5 tubular 611497 recessive 612301 166600 607634 259730 acidosis 2 4 
144750,	144750 Osteosclerosis endosteal Hyperostosis 
259770,	Osteoporosis-pseudoglioma 259770 syndrome 
259500,	somatic Osteosarcoma 259500 
311300,304120,	Otopalatodigital I 304120 syndrome 311300 type II 
215150,184840,	dominant 215150 Otospondylomegaepiphyseal recessive autosomal dysplasia 184840 
166900,	type 166900 SA Ovalocytosis 
614291,613399,new44,612555,604370,167000,	carcinoma 614291 cancer 604370 somatic} Adenocarcinoma Ovarian familial 3} 613399 somatic cancer, ovarian 1} 612555 {Breast-ovarian to 4} susceptibility {Ovarian 2} 167000 
300510,233300,617690,616185,614324,	300510 233300 5 3 616185 617690 2 1 Ovarian 4 dysgenesis 614324 
608115,	608115 hyperstimulation Ovarian syndrome 
276400,	FSH 276400 to stimulation response Ovarian 
603896,	603896 Ovarioleukodystrophy 
185000,	Overhydrated 185000 hereditary stomatocytosis 
609136,	PCWH 609136 syndrome 
167200,167210,615726,615728,	167200 congenita 615728 167210 3 4 2 615726 1 Pachyonychia 
167250,239000,616833,	167250 5 of 3 disease Paget 616833 juvenile-onset 6 239000 bone 
146510,	Pallister-Hall 146510 syndrome 
615255,	615255 carcinoma Palmoplantar multiple self-healing 
616099,600231,615598,613000,600962,144200,615735,104100,	Nagashima 613000 and diffuse 144200 with or 104100 616099 615598 alopecia epidermolytic focal 615735 congenital nonepidermolytic hair 600962 woolly keratoderma 600231 Palmoplantar Bothnian type 
609069,600001,260370,615935,	heart 609069 agenesis and Pancreatic 2 260370 615935 1 defects cerebellar congenital 600001 
606719,614320,new55,613347,606856,613348,260350,	606719 carcinoma cancer Pancreatic or 260350 614320 syndrome melanoma 3} carcinoma, 606856 somatic cancer, 1} 613347 613348 to 4} susceptibility {Pancreatic 2} 
167800,	Pancreatitis 167800 against} {Pancreatitis chronic to} idiopathic} susceptibility hereditary protection 
312000,	Panhypopituitarism 312000 X-linked 
245000,	Papillon-Lefevre 245000 syndrome 
120330,	Papillorenal 120330 syndrome 
614165,605373,115310,601650,606864,168000,	without Paraganglioma 614165 and 601650 with 168000 or 3 1 5 deafness 606864 gastric 115310 605373 Paragangliomas 2 4 sarcoma stromal 
168300,	168300 congenita Paramyotonia 
168400,	Parastremmatic dwarfism 168400 
609597,168500,168550,	Parietal 168500 609597 168550 cleidocranial 2 1 foramina with dysplasia 
608355,	Parkes Weber 608355 syndrome 
607060,612953,615528,260300,605909,600116,610297,168600,605543,168601,616710,616840,613135,607688,614203,614251,606324,615530,	612953 of 168600 616710 614203 late-onset juvenile-onset early-onset modifier} 607060 615528 605909 7 18} 23 dominant to} autosomal 168601 616840 onset 11} 1 6 age 615530 {Parkinson 260300 14 early juvenile 17} recessive 8} 605543 613135 disease 22 infantile 610297 600116 15 19a Parkinson 19b Parkinsonism-dystonia 607688 type 2 13} 20 606324 614251 susceptibility 4 
300818,	nocturnal Paroxysmal somatic hemoglobinuria 300818 
118800,609446,	dyskinesia without generalized 609446 Paroxysmal 3 nonkinesigenic epilepsy 1 118800 with or 
309510,	309510 Partington syndrome 
617039,617035,	ductus 3 arteriosus 617035 2 617039 Patent 
617115,609796,607936,616295,270300,	acral 617115 and pads 616295 with skin syndrome Peeling punctate 1 cheilitis keratoses 5 knuckle 609796 leukonychia 607936 270300 2 4 
169400,	anomaly 169400 Pelger-Huet 
312080,	disease Pelizaeus-Merzbacher 312080 
274600,	Pendred 274600 syndrome 
142680,614674,	614674 dependent 142680 fever Periodic familial cycle menstrual 
170650,	juvenile 170650 Periodontitis 1 
PAS,	Adenoma somatic Periampullary 
614879,614882,614886,614885,614871,614883,614877,614859,614862,266510,614863,214100,614872,614867,614876,614873,614887,202370,614866,601539,214110,614870,	10A (NALD 7A 11A 3B 614879 or 2A 614882 614886 (Zellweger) 614885 614871 6A 614883 614877 8A biogenesis 7B 8B 614859 614862 Peroxisome 266510 4B 614863 6B 3A IRD) disorder 214100 614872 1A 614867 614873 614876 614887 11B 202370 601539 12A 614866 5A 214110 9B 1B 13A 614870 5B 4A 2B 
614129,616138,615300,617565,233400,	614129 Perrault 5 616138 615300 syndrome 617565 3 233400 6 1 4 
168605,	168605 Perry syndrome 
261550,	I syndrome 261550 Mullerian type II Persistent duct 
175200,	175200 Peutz-Jeghers syndrome 
101600,	syndrome Craniofacial-skeletal-dermatologic Pfeiffer 101600 dysplasia 
606232,	606232 Phelan-McDermid syndrome 
171300,	{Pheochromocytoma of} to} 171300 modifier Pheochromocytoma susceptibility 
601815,300653,	601815 dehydrogenase 300653 Phosphoglycerate 1 kinase deficiency 
300661,	300661 Gout superactivity PRPS-related synthetase Phosphoribosylpyrophosphate 
172700,	disease 172700 Pick 
172800,	Piebaldism 172800 
602342,	602342 Pierpont syndrome 
609049,	Pierson 609049 syndrome 
610489,610475,614190,	nodular 610475 primary 3 adrenocortical disease 2 614190 1 610489 Pigmented 
172870,	172870 chorioretinal atrophy paravenous Pigmented 
614325,610042,610954,	610042 like syndrome 610954 Pitt-Hopkins-like Pitt-Hopkins 2 1 614325 
617540,102200,300943,new58,219090,102000,617686,	617540 types 219090 {Pituitary GH-secreting predisposition 300943 3 multiple tumor, 1 types} 5 adenoma somatic ACTH-secreting 102000 102200 invasive 2 4 Pituitary 617686 
182230,613986,262600,262700,221750,613038,	182230 613986 5 262600 3 262700 221750 2 hormone combined 6 1 4 Pituitary 613038 deficiency 
173200,	Pityriasis rubra 173200 pilaris 
613329,	inhibitor-1 Plasminogen 613329 activator deficiency 
601399,614278,617718,608404,	factor 601399 614278 glycoprotein eosinophilia and 608404 Platelet with immune-mediated deficiency 617718 familial acetylhydrolase inflammatory Platelet-activating abnormalities associated myeloid disease disorder IV malignancy 
151210,	Torrance skeletal Platyspondylic type 151210 dysplasia 
601200,	Pleuropulmonary blastoma 601200 
173600,	primary spontaneous Pneumothorax 173600 
615704,604173,	myopathy fibrosis 615704 604173 with and neutropenia fibrosing contractures Poikiloderma pulmonary tendon hereditary 
613095,263200,617610,173900,600666,	without 613095 5 Polycystic 3 4 with 263200 disease 2 617610 1 173900 600666 kidney or hepatic 
617004,174050,	Polycystic disease 2 617004 174050 1 liver 
263300,	vera 263300 somatic Polycythemia 
174500,174200,174700,	174700 types B preaxial Polydactyly IV 174500 A1 and 174200 type II postaxial 
615895,263570,616199,	myopathy without 263570 615895 immunodeficiency 616199 form disease adult 2 Polyglucosan 1 body with or 
606854,616531,615752,	606854 615752 arthrogryposis 616531 hypoplasia with perisylvian and bilateral cerebellar Polymicrogyria frontoparietal 
615803,613811,617695,277470,607596,615851,225753,617026,611523,614961,614969,614678,616081,612389,615809,	615851 615809 8 10 2A 615803 1C 9 7 607596 225753 617026 611523 614961 614678 612389 2D 6 Pontocerebellar 2E 2F 616081 1A 613811 11 617695 277470 hypoplasia 1B type 614969 4 2B 
119500,263650,	Bartsocas-Papas 263650 syndrome Popliteal pterygium type 119500 1 
614483,175780,	Porencephaly 175780 614483 2 1 
175900,616063,175800,616631,614714,	types 9 7 disseminated 614714 3 superficial 616063 616631 Porokeratosis actinic multiple type 175800 1 8 175900 
263700,176200,176000,176100,612740,	cutanea {Porphyria 176100 nonerythroid to} variegata 263700 variant 176000 Porphyria congenital erythropoietic hepatic acute {Lead hepatoerythropoietic 176200 poisoning susceptibility tarda 612740 intermittent 
617068,	hypertension Portal 617068 noncirrhotic 
176270,	Prader-Willi 176270 syndrome 
176410,615346,	central cell adenoma 615346 Precocious Leydig somatic male 176410 puberty 2 precocious with 
new109,614595,609404,	5 Preeclampsia to} {Preeclampsia, 614595 susceptibility eclampsia 4 or 609404 
614391,270960,614390,614389,	3} 270960 {Pregnancy 614391 recurrent 614389 1} susceptibility Pregnancy 614390 to loss 2} 4 
617234,616814,	lethality embryonic 2 Preimplantation 616814 617234 
601812,	601812 syndrome Premature type Penttinen aging 
300510,612964,615724,608996,615723,311360,616946,612310,611548,	615723 8 300510 9 7 612964 3 Premature 311360 616946 6 1 612310 611548 failure Adrenocortical insufficiency 5 608996 ovarian 11 615724 4 
615474,	615474 aldosteronism abnormalities and neurologic Primary seizures 
606353,	lateral juvenile Primary sclerosis 606353 
606688,	course Prion 606688 disease protracted with 
609286,615156,258450,613077,157640,610131,616479,617070,609283,	ophthalmoplegia 615156 258450 deletions with Progressive dominant external 3 autosomal mitochondrial 617070 1 6 DNA 609283 5 recessive 613077 616479 609286 157640 610131 2 4 
606054,	Propionicacidemia 606054 
611928,611868,176807,603688,601518,614731,	611928 cancer {Prostate somatic} or to} 603688 brain familial 1 611868 cancer} 176807 somatic 12} to Prostate 601518 13} 2 susceptibility 614731 hereditary 
308990,	molecular weight 308990 Proteinuria low with nephrocalcinosis hypercalciuric 
176920,	Proteus 176920 somatic syndrome 
300752,177000,	300752 177000 recessive autosomal X-linked Protoporphyria erythropoietic 
300004,	Proud 300004 syndrome 
617397,251290,	syndrome Pseudo-TORCH 2 1 617397 251290 
177170,	Pseudoachondroplasia 177170 
609153,	Pseudohyperkalemia red leak cell 609153 2 familial to due 
264350,614495,614492,177735,614491,614496,	I 264350 614495 IIE dominant IID IIC autosomal 614492 177735 type Pseudohypoaldosteronism 614491 IIB 614496 
612462,603233,103580,	Ia Ic Ib 103580 612462 603233 Pseudohypoparathyroidism type IB 
612463,	612463 Pseudopseudohypoparathyroidism 
264800,177850,610842,	coagulation elasticum-like factor elasticum of of} with severity 610842 Pseudoxanthoma modifier multiple 177850 disorder {Pseudoxanthoma 264800 fruste forme deficiency 
614204,177900,616106,605606,602723,614070,	against} 14 15 614204 to} {Psoriasis 616106 177900 1} 605606 Psoriasis 2 susceptibility 13} 614070 602723 pustular protection 
616373,178500,614743,614742,616371,	616371 616373 fibrosis 178500 Pulmonary 3 to} 4 614743 and marrow 1} 614742 idiopathic susceptibility telomere-related {Pulmonary failure or bone 
609135,614743,	Aplastic anemia} {Aplastic to} 614743 susceptibility anemia 609135 
615344,178600,615343,615342,615371,	without with 615371 or fenfluramine 615344 3 to} 178600 familial 1 615342 neonatal HHT primary Pulmonary hypertension {Pulmonary dexfenfluramine-associated 615343 2 susceptibility 4 
234810,265450,	Pulmonary venoocclusive disease 2 234810 265450 1 
612260,	bacterial recurrent Pyogenic infections to MYD88 612260 due deficiency 
266140,	266140 Pyropoikilocytosis 
312170,608782,614111,266150,266200,245348,	312170 carboxylase E1-beta 614111 phosphatase dehydrogenase 608782 266150 Pyruvate 266200 245348 E2 kinase E1-alpha deficiency 
601709,	601709 Quebec disorder platelet 
612798,	mark isolated 612798 Question ears 
266280,	RAPADILINO 266280 syndrome 
614470,	RAS-associated autoimmune disorder 614470 leukoproliferative 
262190,	262190 Rabson-Mendenhall syndrome 
605432,616738,	thrombocytopenia synostosis 616738 amegakaryocytic 605432 Radioulnar 2 1 with 
300717,300718,	late myopathy 300718 early 300717 childhood 1b 1a severe onset adult X-linked infantile body with or Reducing 
144700,605074,300854,	1 144700 carcinoma cell papillary somatic 300854 and Renal clear {Renal familial 605074 chromophobe carcinoma} 
137920,	syndrome and Renal diabetes cysts 137920 
191830,208540,601331,	cystic hypodysplasia 601331 Renal-hepatic-pancreatic 191830 208540 to} Renal {Renal susceptibility 1 aplasia dysplasia or 
267300,604278,179800,611590,602722,	AR ocular tubular 179800 AD distal abnormalities recessive 604278 autosomal deafness acidosis Renal 611590 267300 602722 with proximal 
267430,	Renal dysgenesis tubular 267430 
275210,	Restrictive lethal 275210 dermopathy 
615537,	of 615537 Kitamura acropigmentation Reticulate 
610478,610125,610024,615147,617547,new60,617175,613341,248200,610356,605670,	without 610125 degeneration clumped 615147 617547 pigment 3B and late-onset cone early-onset with comedogenic or dysfunction macular 610478 coloboma pituitary 610024 dominant syndrome 3 autosomal staphyloma dystrophy severe 248200 iris 605670 anomalies Retinal extraocular recessive, degeneration, 613341 617175 acne type 610356 4 
250410,610282,613861,613767,617304,613983,616469,612095,610359,136880,614181,610599,600059,608133,608380,300029,613581,616394,616544,300455,609923,613758,617023,180105,312600,612943,614180,602772,612572,613582,614500,617123,180100,601718,604232,600132,617781,613809,613810,613769,615922,613731,613341,611131,617433,600138,615434,616959,600105,601414,615725,606068,615780,613862,613756,613827,607921,616562,613194,613801,617460,613428,613794,613660,600852,613750,	microcytosis 613861 616469 136880 300029 612943 612572 autosomal 30 59 600132 38 anomalies 60 14 juvenile 64 611131 617433 inversus 600105 601414 615780 42 75 607921 613194 617460 2 613794 600852 613750 13 610282 19 613983 and Retinitis 612095 610359 614181 610599 616394 609923 61 albescens 35 47 skeletal 3 77 43 80 615922 37 613341 28 26 606068 11 54 31 616562 20 without 250410 613767 46 44 608133 with 78 68 7 45 617023 312600 617123 614180 602772 613582 601718 pigmentosa-12 74 72 digenic 604232 617781 62 pigmentosa-40 27 deafness concentric 25 73 49 76 600138 615434 616959 71 613862 613827 18 613810 57 617304 erythrocytic 65 616544 600059 300455 608380 or 613581 10 613758 180105 dominant 614500 48 180100 33 pigmentosa 36 1 situs 613809 613769 sinorespiratory 613731 70 recessive infections 41 56 X-linked punctata 69 615725 39 613756 17 613801 613428 79 pigmentosa-50 613660 4 
180200,	180200 trilateral Retinoblastoma 
613454,312750,	613454 speech syndrome Rett atypical variant 312750 preserved congenital 
268130,	syndrome 268130 Revesz 
609322,613325,	predisposition syndrome tumor somatic tumors 1} {Rhabdoid 609322 Rhabdoid 613325 2} 
268210,268220,180295,	268210 embryonal Rhabdomyosarcoma somatic 2 alveolar 180295 268220 
616716,215100,600121,222765,	Rhizomelic 616716 5 3 222765 type 2 chondrodysplasia punctata 1 215100 600121 
208530,	isomerism 208530 atrial Right 
180550,	180550 of Ring dermoid cornea 
606072,	disease 606072 muscle Rippling 
220210,300963,	syndrome 220210 2 1 Ritscher-Schinzel 300963 
268300,	268300 Roberts syndrome 
180700,616894,616331,268310,	616331 syndrome dominant 3 616894 autosomal recessive Robinow 2 1 180700 268310 
180750,	180750 Robinow-Sorauf syndrome 
268400,	268400 syndrome Rothmund-Thomson 
180800,	Roussy-Levy 180800 syndrome 
613684,180849,	syndrome 2 Rubinstein-Taybi 1 613684 180849 
616482,	616482 SADDAN 
603736,	SBBYSS 603736 syndrome 
269000,	phocomelia SC 269000 syndrome 
183900,184095,	congenita 184095 183900 type SED Maroteaux 
612780,	612780 SESAME syndrome 
269880,	269880 SHORT syndrome 
184250,	type SMED 184250 Strudwick 
615709,	anomalies 615709 Sacral agenesis vertebral with 
101400,	eyelid without anomalies Saethre-Chotzen syndrome 101400 with or 
611705,	myopathy 611705 Salih 
604369,	Salla disease 604369 
609579,	maxillary retardation Scaphocephaly and 609579 retrusion mental 
181430,300695,181405,181400,	myopathy spinal muscular 181400 syndrome dominant myopathic 300695 181405 181430 type neurogenic X-linked Scapuloperoneal atrophy Kaeser 
163200,	mosaic syndrome somatic 163200 Schimmelpenning-Feuerstein-Mims 
609241,	I III Schindler 609241 disease type 
269150,	retraction Schinzel-Giedion syndrome midface 269150 
269160,	Schizencephaly 269160 
224750,	224750 Schopf-Schulz-Passarge syndrome 
615670,162091,	{Schwannomatosis-2 to} 162091 {Schwannomatosis-1 615670 susceptibility Schwannomatosis 
255800,	syndrome Schwartz-Jampel 255800 type 1 
617394,	617394 neonatal Sclerosing cholangitis 
614305,269500,	2 1 614305 269500 Sclerosteosis 
269600,	histiocyte Sea-blue disease 269600 
605249,	605249 Sebastian syndrome 
606744,617253,210600,613823,616777,	5 617253 606744 9 syndrome 210600 2 613823 1 616777 Seckel 10 
616632,617080,605751,607745,121200,121201,	blindness Myokymia microcephaly 616632 617080 syndrome Seizures 3 familial 1 neonatal 5 607745 infantile benign cortical 605751 type 2 121200 121201 
212350,	212350 Sengers syndrome 
616629,609254,610189,616307,606996,613615,266900,	Senior-Loken 5 9 7 609254 syndrome 616629 610189 616307 6 606996 8 syndrome-1 4 613615 266900 
300400,602450,601457,611291,608971,	killer-cell T Athabascan B 300400 killer and B-cell T-cell with growth or sensitivity microcephaly retardation immunodeficiency 602450 611291 608971 cell-positive cell-negative combined X-linked radiation to natural Severe negative 601457 type ionizing positive 
615328,	Shaheen 615328 syndrome 
609621,609622,609620,	Short syndrome QT 3 609621 2 609620 1 609622 
614800,617763,165800,617164,617044,617157,616541,614813,616255,602471,300582,615789,	retinitis without hypotrichosis intellectual atresia brachydactyly 616541 and 616255 early-onset 300582 facies with or dysfunction bone atrophy Short 617763 microcephaly micrognathia skeletal dysmorphism osteochondritis 617157 614813 Pelger-Huet facial pigmentosa defects familial auditory age mandibular loss congenital optic 615789 endocrine disability rhizomelic abnormalities 617044 onychodysplasia distinctive idiopathic osteoarthritis delay 614800 dissecans advanced 165800 canal stature hypoplasia 617164 nerve anomaly 602471 developmental heart hearing seizures nonspecific 
617088,611263,613819,616300,615633,615630,614091,617102,613091,617405,263520,615503,266920,616546,	without 613819 616300 614091 613091 617405 263520 266920 616546 8 with 615503 or 10 617088 9 7 615630 3 617102 thoracic 6 dysplasia 611263 14 615633 polydactyly 16 11 15 17 2 4 13 Short-rib 
260400,	Shwachman-Diamond 260400 syndrome 
256550,269920,	I 269920 storage acid Sialidosis 256550 type Sialic disorder infantile II 
269921,	269921 Sialuria 
608567,163800,614090,	608567 3} 163800 614090 syndrome {Sick 2 sinus 1 Sick 
603903,	603903 Sickle anemia cell 
616084,	616084 Sideroblastic immunodeficiency delay and B-cell developmental anemia with periodic fevers 
270685,	270685 paraplegia syndrome Silver spastic 
300209,312870,	300209 syndrome 312870 Simpson-Golabi-Behmel type 2 1 
147250,	147250 central median maxillary incisor Single 
616298,182250,	Singleton-Merten syndrome 182250 2 1 616298 
614896,	614896 deafness Sinoatrial and node dysfunction 
210250,	Sitosterolemia 210250 
612447,	Skeletal retardation hypoplasia and genital 612447 defects mental 
607655,	syndrome fragility-woolly 607655 hair Skin 
133020,	Erythermalgia fiber neuropathy primary Small 133020 
616638,	616638 Smith-Kingsmore syndrome 
607326,615222,	607326 Smith-McCort 2 615222 dysplasia 
614753,117550,	117550 syndrome 2 Sotos 614753 1 
604360,604805,612539,613744,611390,609195,614409,617296,615683,615491,605280,182601,270550,601162,604187,615035,611225,615030,612319,615033,614487,617225,616657,270750,616586,609340,312920,600363,613206,617560,614066,614898,611302,615681,610250,182600,607259,108600,609541,610357,614067,612020,616756,615031,270800,607225,270700,613647,612936,616680,613162,616907,603563,610244,	604360 613744 9A 617296 51 615683 8 leukodystrophy 52 ascending 601162 nystagmus obesity psychomotor retardation 611225 autosomal 615030 617225 30 270750 6 312920 600363 disability 53 617560 611302 615681 64 607259 callosum 609541 15 paraplegia 612020 42 5A 270700 270800 75 616756 tetraplegia 2 13 seizures and 605280 182601 progressive 270550 12 microcephaly 35 47 23 3 612319 onset 609340 613206 614898 Spastic 28 26 614067 610357 11 9B 607225 54 31 type 616907 609195 without 612539 46 44 with 78 604187 7 45 614487 616657 optic 62 thin hypomyelinating corpus 3A 49 76 paralysis 182600 108600 615031 18 614066 604805 ataxia 611390 614409 intellectual Charlevoix-Saguenay 615491 55 or atrophy 10 dominant 615035 50 48 615033 33 616586 1 5 recessive 610250 56 X-linked infantile 39 neuropathy 613647 79 612936 616680 613162 603563 4 610244 
616859,	childhood-onset 616859 hyperglycinemia with Spasticity 
245480,617475,	deficiency Specific 245480 2 granule 617475 
273300,	Spermatocytic cell tumor seminoma 273300 somatic tumors Testicular germ somatic} tumor, {Male Germ 
270960,617187,243060,613958,309120,612997,617592,415000,614822,615081,606766,613957,617576,615413,	309120 612997 19 415000 614822 615081 606766 8 10 12 270960 9 243060 7 617592 3 4 613957 failure Spermatogenic 5 X-linked 613958 16 615413 617187 11 Y-linked 18 2 617576 
182900,616649,270970,612690,612653,	182900 5 3 616649 Spherocytosis 2 type 1 270970 4 612690 612653 
253300,159950,600175,614881,615290,182980,313200,253550,611067,158600,616866,271150,615048,300489,301830,253400,	of atrophy-3 Finkel 615290 and late-onset atrophy-4 fractures progressive with atrophy 301830 extremity-predominant lower bone {Spinal 159950 600175 3 autosomal 313200 atrophy-1 modifier 611067 Spinal 1 bulbar Jokela congenital 253300 5 AD distal of} recessive X-linked infantile 271150 615048 300489 182980 Kennedy 253400 muscular III atrophy-2 614881 myoclonic epilepsy 253550 type 2 158600 616866 nonprogressive 4 
615768,600224,615386,133190,608768,610743,617769,616354,607346,606658,607136,616719,604326,615957,616795,614229,603516,604432,164400,610245,614322,213200,613728,117360,616204,607250,613908,609307,605361,183086,610246,615945,117210,614831,616949,614153,164500,617691,606002,605259,616127,609270,607454,183090,	615768 nonprogressive ataxia 600224 615386 19 133190 608768 610743 617769 616354 607346 44 606658 607136 8 with 616719 axonal 604326 10 12 35 615957 23 45 7 616795 614831 autosomal 614229 603516 604432 164400 1 610245 36 6 congenital 614322 213200 613728 38 117360 34 27 5 14 neuropathy 37 616204 recessive 607250 29 613908 28 16 605361 609307 183086 616949 610246 11 15 117210 615945 17 614153 42 617691 31 164500 606002 605259 Spinocerebellar 2 616127 18 20 609270 21 607454 13 183090 
616890,225300,605289,	616890 605289 malformation mesoaxial 4 225300 Split-hand 6 polydactyly Split-foot with foot or 
272460,	synostosis 272460 Spondylocarpotarsal syndrome 
122600,277300,613686,608681,	277300 5 608681 recessive autosomal Spondylocostal 122600 2 613686 1 dysostosis 4 
603546,300106,143095,313400,271640,610442,616723,602111,208230,608728,616583,	without Stanescu of 610442 fractures 602111 208230 progressive with or dislocations joint 616723 1 dysplasia congenital 616583 Arthropathy childhood 603546 pseudorheumatoid Missouri 300106 313400 X-linked Faden-Alkuraya 608728 arthropathy Spondyloepiphyseal 143095 Spondyloepimetaphyseal Camera-Genevieve 271640 type 2 tarda laxity 
608940,250220,184252,602271,613320,	cone-rod Kozlowski Spondylometaphyseal Sedaghatian 608940 dystrophy type 250220 axial 184252 602271 613320 with dysplasia Megarbane-Dagher-Melike 
605822,	Spondyloocular 605822 syndrome 
271700,	271700 dysplasia Spondyloperipheral 
275355,	carcinoma cell 275355 somatic and head neck Squamous 
new80,	cell scar-related, burn somatic Squamous carcinoma, 
184460,	broad and 184460 toes with thumb Stapes ankylosis 
248200,603786,600110,	603786 3 disease 248200 Stargardt 1 4 600110 
184500,	184500 Steatocystoma multiplex 
614134,609508,108300,604841,	I Stickler 609508 ocular nonsyndromic IV syndrome 614134 604841 type II 108300 
184900,	skin 184900 Stiff syndrome 
608885,	cryohydrocytosis neurologic defects 608885 Stomatin-deficient with 
185070,	Stormorken 185070 syndrome 
609161,616922,	degeneration dominant Striatal autosomal 616922 609161 
271930,617054,	Striatonigral degeneration childhood-onset 271930 617054 infantile 
185300,	mosaic Sturge-Weber syndrome 185300 somatic 
184450,	Stuttering persistent 184450 familial 1 
272120,608800,	death of syndrome infant with to} 608800 {Sudden 272120 susceptibility testes Sudden dysgenesis the 
601104,260540,	Supranuclear 260540 atypical palsy 601104 progressive 
185500,	aortic stenosis 185500 Supravalvar 
265120,610921,614370,610913,300770,	Surfactant 300770 5 metabolism 3 265120 610921 2 614370 pulmonary 1 4 dysfunction 610913 
617746,	Sweeney-Cox 617746 syndrome 
156610,616734,	skin 616734 creases Symmetric 156610 2 circumferential 1 congenital 
615298,185800,	615298 185800 1B Symphalangism 1A proximal 
609432,186200,186100,186300,	186300 186200 phalangeal reduction III IV Syndactyly mesoaxial 609432 type 186100 synostotic V with 
186000,	186000 Synpolydactyly 1 
152700,612251,612253,614420,609939,601744,610927,605218,	152700 6} 612253 609939 601744 10} 610927 lupus 605218 erythematous Systemic with resistance to} 614420 nephritis 9} 11} {Lupus association {Systemic 1} 16 to erythematosus 612251 susceptibility 2} 
601705,614868,	nail recurrent immunodeficiency infections alopecia and dystrophy cardiac 601705 autoimmunity malformations T-cell congenital 614868 
205400,	disease 205400 Tangier 
186570,	186570 coalition Tarsal-carpal syndrome 
600376,187300,615506,	187300 5 hemorrhagic 600376 type 2 615506 1 hereditary Telangiectasia 
611816,	Temple-Baraitser 611816 syndrome 
300244,	osseous dysplasia Terminal 300244 
187500,	Tetralogy of Fallot 187500 
new82,613985,603902,604131,141749,	Hispanic Thalassemias 613985 Thalassemia 141749 thalassemia Lepore Hb dominant Thalassemia-beta gamma-delta-beta beta- delta- 604131 inclusion-body 603902 to Thalassemia, due Delta-beta alpha- 
187600,187601,	I Thanatophoric type 187600 187601 II dysplasia 
607483,249270,613710,614458,	2) 613710 249270 614458 anemia dysfunction or syndrome megaloblastic Thiamine (biotin- (progressive (episodic Thiamine-responsive 5 type) encephalopathy thiamine-responsive metabolism polyneuropathy type 2 607483 4 
614521,601977,187950,	601977 187950 Thrombocythemia 3 614521 somatic 2 1 
274000,616216,188000,273900,new84,313900,612004,300367,604498,314050,	274000 without 188000 Thrombocytopenia 612004 anemia 300367 beta-thalassemia alloimmune, 314050 with radius or dyserythropoietic syndrome 273900 3 alloimmune 313900 congenital Thrombocytopenia-absent 5 neonatal amegakaryocytic antigen BAK X-linked 604498 related 616216 2 Thrombocytopenia, 4 intermittent 
613116,612304,188050,188055,613118,612356,612336,614486,614514,176860,300807,	factor IX cofactor 613118 612356 V 614514 activated venous deficiency 613116 thrombin resistance 188050 thromboembolism {Thromboembolism dominant to} autosomal Leiden} protein protection HRG Thrombophilia 612304 188055 {Venous recessive C S 612336 X-linked II thrombomodulin antithrombin to due 300807 {Deep {Thrombophilia against} defect heparin III susceptibility thrombosis 614486 176860 
new59,274150,	Thrombotic 274150 Purpura, purpura posttransfusion familial thrombocytopenic 
607464,616534,155240,188550,188470,new56,145001,new83,608266,	cystic carcinoma adenoma, cancer nonmedullary somatic} with 607464 thyrotoxicosis Thyroid familial 145001 608266 Hurthle follicular adenoma somatic 188550 cell} 1} Parathyroid {Thyroid 2} 616534 155240 Medullary 4} 188470 changes thyroid hyperfunctioning, 
274800,274400,274900,607200,274700,274500,	2A dyshormonogenesis 274800 5 274400 3 4 Thyroid 274900 6 1 607200 274700 274500 
274300,609698,188570,145650,	609698 metabolism resistance 188570 pituitary abnormal selective recessive 145650 autosomal Thyroid 274300 hormone 
600334,	muscular tardive 600334 Tibial dystrophy 
103500,	Tietz 103500 albinism-deafness syndrome 
601005,	601005 Timothy syndrome 
607523,	dystrophy 607523 isolated Toenail 
617275,617073,604625,106600,616724,313500,150400,	orofacial without 8 with or 9 7 selective 3 1 617275 cleft 617073 313500 604625 X-linked 106600 150400 agenesis Tooth 616724 4 
137580,	la {Gilles syndrome to} Tourette 137580 susceptibility de 
131705,	of bullous newborn Transient 131705 the 
608808,613854,	608808 the of 3 dextro-looped 1 arteries great Transposition 613854 
248390,154500,613717,	syndrome 3 613717 2 154500 248390 Collins 1 Treacher 
190320,	190320 Trichodontoosseous syndrome 
601606,	multiple familial 1 601606 Trichoepithelioma 
614602,222470,	Trichohepatoenteric syndrome 2 222470 1 614602 
616943,234050,616395,616390,601675,	616943 3 234050 photosensitive 616395 2 Trichothiodystrophy 6 616390 1 601675 nonphotosensitive 4 
609015,	protein 609015 Trifunctional deficiency 
614485,190440,	190440 Trigonocephaly 2 1 614485 
174500,	I syndrome 174500 type Triphalangeal thumb-polysyndactyly thumb 
158300,	Trismus-pseudocamptodactyly 158300 syndrome 
608189,	to} diabetes pancreatic {Fibrocalculous calcific 608189 susceptibility pancreatitis Tropical 
613254,191100,	of} 191100 613254 sclerosis-2 renal modifier angiomyolipomas {TSC2 Tuberous sclerosis-1 
610455,211900,	normophosphatemic Tumoral familial hyperphosphatemic calcinosis 610455 211900 
276710,276600,276700,	I III Tyrosinemia type 276710 276600 276700 II 
600630,614621,614640,	600630 UV-sensitive syndrome 3 2 1 614621 614640 
254090,	muscular Ullrich dystrophy 254090 1 congenital 
276820,	276820 of limb absence and severe fibula Ulna with deficiency 
615112,236730,	syndrome 615112 236730 2 1 Urofacial 
606943,611383,276904,276902,605472,601067,614869,276901,614504,602083,276900,	{Retinal IIA Usher 276902 3B 614869 276901 614504 GPR98 or 2A 1C 606943 syndrome 1D 276904 601067 modifier F 2D 1F 602083 digenic 2C of} 605472 in 3A disease 1G IJ 611383 IIC 1B type PDZD7 276900 
314390,	VACTERL association X-linked 314390 
276950,	VATER association macrocephaly ventriculomegaly and 276950 with 
239100,	Van disease 239100 Buchem 
615546,601390,	601390 syndrome Van 2 1 Maldergem 615546 
192315,	retinal Vasculopathy 192315 leukodystrophy with cerebral 
192430,	Velocardiofacial 192430 syndrome 
600195,	mucosal 600195 and cutaneous multiple Venous malformations 
603829,612956,	{Ventricular Ventricular paroxysmal 612956 603829 familial 1 fibrillation 2} 
614431,614432,614429,	septal defect 1 Ventricular 614431 614432 3 2 614429 
615441,614916,192605,611938,614021,604772,	tachycardia without Ventricular 614916 192605 with 614021 or 3 1 604772 5 muscle 611938 idiopathic catecholaminergic polymorphic weakness 615441 2 4 
219730,	cystic disease Ventriculomegaly 219730 with kidney 
617660,617661,	limb syndrome and renal cardiac Vertebral 2 defects 1 617660 617661 
610878,613674,615963,	reflux 3 Vesicoureteral 610878 2 613674 615963 8 
607473,277450,	Vitamin clotting of factors K-dependent 607473 2 combined 1 277450 deficiency 
604117,124500,	604117 124500 syndrome Vohwinkel ichthyosis with 
193670,	WHIM 193670 syndrome 
148820,613265,277580,103470,608890,193500,611584,193510,613266,	without 611584 with or 2A 148820 syndrome 3 277580 103470 2D 608890 1 digenic ocular 2E 4B albinism 613265 193510 613266 involvement Waardenburg neurologic type 193500 4C 4A 
614222,614225,600118,615663,	600118 614225 syndrome 3 614222 micro 2 615663 1 4 Warburg 
122700,	122700 resistance {Warfarin sensitivity} Coumarin Warfarin sensitivity 
193520,	Watson 193520 syndrome 
613195,608328,277600,	Weill-Marchesani 613195 syndrome dominant recessive 277600 2 1 608328 Weill-Marchesani-like 
193530,	Weyers dysostosis acrofacial 193530 
615785,193900,	sponge White 615785 2 193900 1 nevus 
601583,194071,194070,616806,	tumor {Wilms to} somatic 194070 616806 type 2 Wilms 194071 6 1 susceptibility 601583 susceptibility-5} 
301000,	301000 Wiskott-Aldrich syndrome 
194200,	194200 Wolff-Parkinson-White syndrome 
222300,604928,614296,	222300 syndrome dominant autosomal 614296 Wolfram 2 1 Wolfram-like 604928 
194300,616760,278150,604379,	hypotrichosis 1 without 604379 dominant recessive 3 autosomal hair 278150 2 616760 Woolly 194300 with or 
278250,	skin Wrinkly 278250 syndrome 
603592,278300,	I 603592 278300 type II Xanthinuria 
278720,278730,278780,610651,278750,278740,278760,278700,	278720 pigmentosum B D 278740 or 278730 278780 610651 syndrome variant F 278760 DDB-negative 278750 G Cockayne C subtype group A type E 278700 Xeroderma 
216340,	216340 syndrome Yunis-Varon 
135500,616455,	syndrome 135500 616455 2 1 Zimmermann-Laband 
607636,	607636 van Buchem disease 2 type 
119300,	Woude syndrome van 119300 der 
193300,	{von syndrome of} von modifier 193300 Hippel-Lindau 
613554,277480,193400,177820,	2A 1 2M types 277480 193400 3 and von disease type 2N platelet-type 613554 Willebrand Willibrand 177820 2B 
new70,609423,	slow HIV1 susceptibility/resistance {Rapid disease, or infection, resistance from to} 1 {AIDS AIDS viremia of} rapid infection} infection to progression delayed 609423 {HIV1 {HIV type susceptibility {HIV-1 
103780,	against} to} {Alcohol susceptibility 103780 protection dependence 
607154,	rhinitis to} {Allergic susceptibility 607154 
610460,616903,	poor metabolism of 2} 1} 616903 {Thiopurines 610460 
607834,	607834 personality traits} {Anxiety-related 
606788,610269,	606788 nervosa to} 610269 {Anorexia susceptibility 
300497,300494,	syndrome 300497 1} {Asperger susceptibility X-linked 2} 300494 
614079,	614079 to} susceptibility {Aspergillosis 
147050,	to} susceptibility 147050 {Atopy 
143465,613003,	613003 to} disorder} {Attention susceptibility disorder 7} deficit-hyperactivity 143465 to 
615032,300847,300495,613436,300872,300425,612100,300830,615091,300496,	15} 615032 6} 300847 613436 612100 18} {Autism 300872 300425 3} 615091 300496 5} 300495 17} 1} X-linked 300830 to 19} 4} susceptibility 2} 
614383,614382,	{Bacteremia against} 614383 to} susceptibility protection 614382 
606798,	primary 606798 benign} {Blepharospasm 
600880,	600880 syndrome somatic} {Budd-Chiari syndrome} 
607499,	weight in} of nervosa {Bulimia onset age loss 607499 
610446,	{Buruli to} 610446 susceptibility ulcer 
609755,212750,609753,	{Celiac 609753 to} disease 4} 212750 susceptibility 3} 609755 to 
120080,	120080 {Colchicine resistance} 
617347,607339,143890,608320,610947,610938,614466,608901,new67,	6} 2, disease, resistance dominant to} autosomal severe modifier familial {Coronary spasm protection hypercholesterolemia 617347 5} 607339 610938 of} 614466 in artery 1} disease to against} 143890 610947 608320 608901 1, susceptibility heart 7} 2} 
614371,	{Dengue against} fever 614371 protection 
605803,	atopic susceptibility {Dermatitis 605803 2} to 
614212,608033,	infection-induced acute 3 to} {Encephalopathy susceptibility 608033 614212 4 
606657,	606657 tension to} normal susceptibility {Glaucoma 
614395,	614395 against} {Graft-versus-host disease protection 
600263,	to} susceptibility 600263 infection {H. pylori 
140300,	140300 {Hashimoto thyroiditis} 
614519,	614519 to} {Stroke hemorrhagic} susceptibility {Hemorrhage intracerebral 
609532,610424,	609532 B resistance 610424 of} to} C virus susceptibility to infection therapy response {Hepatitis 
614850,613002,610551,	6} encephalitic 614850 610551 encephalitis 1} 613002 susceptibility simplex {Herpes 2} to 
600155,613712,613711,142623,	{Hirschsprung 142623 613711 613712 600155 1} disease 4} susceptibility 3} 2} to 
new90,608579,	{Hypersensitivity 608579 syndrome necrolysis to} {Abacavir susceptibility hypersensitivity, {Stevens-Johnson epidermal {Toxic carbamazepine-induced 
241800,	somatic} hamartomas 241800 {Hypothalamic 
108010,	{Intracranial cerebrovascular to} in hemorrhage brain susceptibility malformations 108010 
148000,	{Kaposi to} 148000 susceptibility sarcoma 
245300,	to} 245300 susceptibility {Kuru 
608556,	to} {Legionnaire disease susceptibility 608556 
246300,613223,610988,607572,	against} 5} 610988 to} 613223 607572 {Leprosy 246300 4} susceptibility to protection 
603932,	603932 degeneration} {Intervertebral to} herniation {Lumbar disease susceptibility disc 
612371,608516,	{Major affective and citalopram accelerated disorder-7 antidepressant {Unipolar in} to} 612371 response {Seasonal depression depressive drug treatment} 608516 disorder to susceptibility therapy 
611162,609148,	611162 malaria reduced cerebral risk resistance to} severe protection mild of} deficiency} vivax {Resistance 609148 due to against} G6PD {Malaria susceptibility 
615557,	to} susceptibility {Melioidosis 615557 
612634,612624,612635,612623,612633,612628,603933,	3} 5} 6} of 612634 612624 612635 612623 {Microvascular 612633 diabetes 1} 4} complications 7} 612628 2} 603933 
254500,	resistance {Multiple to} 254500 susceptibility myeloma 
126200,614810,	progression 5} {Multiple of} 614810 modifier disease 1} susceptibility 126200 sclerosis to 
132800,	epithelioma {Multiple squamous to} susceptibility 132800 self-healing 
146500,	146500 {Multiple system to} susceptibility atrophy 
607948,	against} {Mycobacterium to} tuberculosis {Tuberculosis by} 607948 susceptibility infection to protection 
608446,new106,	against} {Myocardial to} infarction, infarction susceptibility 608446 decreased protection 
188890,612052,	{Nicotine against} {Lung to} 612052 cancer susceptibility addiction 188890 from} 2} protection dependence 
258660,	{Nonarteritic neuropathy to} susceptibility ischemic 258660 optic anterior 
164230,	against} to} disorder} {Obsessive-compulsive 164230 susceptibility disorder protection 
607278,	to} dysplasia susceptibility {Osteofibrous 607278 
602080,	of {Paget 602080 disease 2 early-onset} bone 
167870,	to} 167870 susceptibility disorder {Panic 
610504,	of 610504 rupture to} membranes premature susceptibility {Preterm the 
607507,	arthritis 607507 to} {Psoriatic susceptibility 
180300,604302,	progression arthritis juvenile of} to} 180300 susceptibility {Rheumatoid systemic 604302 juvenile} 
612387,181000,	1} susceptibility 181000 {Sarcoidosis 2} to 612387 
614332,613950,181500,604906,617629,600850,	614332 15} 9 17} 19 to} 613950 {Schizophrenia 4} susceptibility to 181500 604906 617629 600850 
106300,	106300 {Spondyloarthropathy 1} susceptibility to 
613239,188580,	613239 {Thyrotoxic 2} 188580 1} susceptibility periodic paralysis to 
266300,	skin {UV-induced 266300 damage} 
612542,	QTL1} B12 plasma {Vitamin 612542 level 
606579,	606579 autoimmune {Vitiligo-associated 1} disease multiple susceptibility 
610379,	nile to} virus susceptibility {West 610379 
617321,	syndrome} 617321 {Yao 
new01,	adenoma somatic Adrenal 
new02,	ratio Aldosterone renin to raised 
new03,	Alpha-1-antichymotrypsin deficiency 
new06,	somatic Angiofibroma 
new10,	nervous Autonomic system dysfunction 
new12,	reduced agonist to Beta-2-adrenoreceptor response 
new14,	lung of tumor Carcinoid 
new15,	disease occlusive Cerebrovascular 
new16,	phosphorylase to kinase due Cirrhosis liver deficiency 
new22,	I inhibition resistance of amsacrine by topoisomerase to II DNA camptothecin-resistant 
new28,	alpha Erythremias beta 
new31,	Hemangioblastoma somatic cerebellar 
new32,	Hematuria, benign familial 
new33,	elevated Homocysteine plasma total 
new34,	hypercalcemia Hypercalciuric 
new43,	carcinoma, Merkel somatic cell 
new46,	Mucoepidermoid gland carcinoma salivary 
new47,	syndrome, syndrome Myelodysplastic preleukemic Myelodysplasia syndrome-1 
new48,	isolated Myelokathexis, 
new119,	Neurofibrosarcoma 
new53,	multiple cancer, Orolaryngeal 
new54,	hamartoma PTEN tumor syndrome 
167400,	pain Paroxysmal disorder extreme 167400 
new61,	Rh-mod syndrome 
new64,	Axenfeld-Rieger anomaly and Scaphocephaly 
new68,	of} response, and modifier beta-blocker heart {Congestive failure 
new71,	{Atherosclerosis, susceptibility to} 
new81,	without elevation CF chloride Sweat 
new86,	{Drug-induced flucloxacillin} injury due to liver 
new87,	cholesterol {High QTL lipoprotein 7} level density 
new88,	granulomatosis Wegener-like 
new89,	metabolizer poor Tolbutamide 
new91,	against} {Aerodigestive squamous tract cancer, alcohol-related, protection cell, 
new92,	toxicity, to} susceptibility {Benzene 
new94,	of} progression {SARS, 
new95,	infection, resistance to} {Norwalk virus 
new96,	of} {Calcium, level serum 
new102,	{Hypertrypsinemia, neonatal} 
new103,	inherited} {Leanness, 
new104,	hypertension, to} {Low susceptibility renin 
new105,	susceptibility to} {Memory impairment, 
new107,	poisoning, {Organophosphate to} sensitivity 
new108,	{Placental abruption} 
new110,	shock, to} {Septic {Sepsis, susceptibility 
new111,	{Sezary syndrome, somatic} 
new113,	poor response to} susceptibility {Sublingual nitroglycerin, to 
new114,	chronic, susceptibility to} {Synovitis, 
new115,	of modulator {Transcription inhibitor, plasminogen of} activator 
new116,	susceptibility to} {Vascular disease, 
new117,	{Venoocclusive after marrow transplantation} disease bone 
new118,	{Viral infection, susceptibility to} 
